RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
DI PERRI G
Collezione ASL Città di Torino
Items : 287
How Antiretroviral Drug Concentrations Could Be Affected by Oxidative Stress, Physical Capacities and Genetics: A Focus on Dolutegravir Treated Male PLWH. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2025 Jan 13;14(1):82. doi: 10.3390/antiox14010082.
2025
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; Lupo C; Rainoldi A; Di Perri G; Bonora S; Trevisan G; Cuomo S; Tettoni MC; Chiara F; Mula J; Antonucci M; Bianco G; Accardo G; Palermiti A; Ferrara M; Manca A; Mulasso A; Cusato J;
The cerebrospinal fluid virome in people with HIV: links to neuroinflammation and cognition. in bioRxiv : the preprint server for biology / bioRxiv [Preprint]. 2025 Feb 28:2025.02.28.640732. doi: 10.1101/2025.02.28.640732.
2025
ASL Città di Torino
Trunfio M; Scutari R; Fox V; Vuaran E; Dastgheyb RM; Fini V; Granaglia A; Balbo F; Tortarolo D; Bonora S; Perno CF; Di Perri G; Alteri C; Calcagno A;
Switching to Low Neurotoxic Antiretrovirals to Improve Neurocognition Among People Living With HIV-1-Associated Neurocognitive Disorder: The MARAND-X Randomized Clinical Trial. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2024 Oct 1;97(2):180-191. doi: 10.1097/QAI.0000000000003480.
2024
ASL Città di Torino
AOU Novara
Di Perri G; Calcagno A; Bonora S; Trentalange A; Trunfio M; Giaccone C; Noce G; Ghisetti V; Tettoni MC; Nigra M; Guastamacchia G; Stroffolini G; Pirriatore V; Barco A; Lazzaro A; Vai D;
Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational Study. in AIDS and behavior / AIDS Behav. 2024 Nov;28(11):3643-3654. doi: 10.1007/s10461-024-04440-w. Epub 2024 Jul 30.
2024
ASL Città di Torino
Calcagno A; Letendre SL; Bonora S; Di Perri G; Cinnirella G; Imperiale D; Di Stefano A; Quarta C; Vuaran E; Vai D; Trunfio M;
Ritonavir: 25 Years' Experience of Concomitant Medication Management. A Narrative Review. in Infectious diseases and therapy / Infect Dis Ther. 2024 May;13(5):1005-1017. doi: 10.1007/s40121-024-00959-6. Epub 2024 Apr 12.
2024
ASL Città di Torino
Quercia R; Di Perri G; Pein C; Bodie J; Singh RSP; Hendrick V; Boffito M;
Intrathecal production of anti-Epstein-Barr virus viral capsid antigen IgG is associated with neurocognition and tau proteins in people with HIV. in AIDS (London, England) / AIDS. 2024 Mar 15;38(4):477-486. doi: 10.1097/QAD.0000000000003775. Epub 2023 Nov 7.
2024
ASL Città di Torino
AOU Città della Salute di Torino
Calcagno A; Di Perri G; Letendre SL; Bonora S; Imperiale D; Cavallo R; Pittaluga F; Croce M; Trunfio M; Sacchi A; Vai D;
Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIV. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2024 Jun;63(6):107137. doi: 10.1016/j.ijantimicag.2024.107137. Epub 2024 Ma
2024
ASL Città di Torino
D'Avolio A; Di Perri G; Bonora S; Trunfio M; Antonucci M; Marinaro L; Avataneo V; Mula J; Palermiti A; Manca A; Cusato J; Calcagno A;
Further considerations on the use of cerebrospinal fluid C-X-C motif chemokine ligand 13 in the diagnosis of neurosyphilis among people with HIV. in AIDS (London, England) / AIDS. 2024 Jul 1;38(8):1273-1275. doi: 10.1097/QAD.0000000000003902. Epub 2024 May 30.
2024
ASL Città di Torino
Trunfio M; Bonora S; di Perri G; Calcagno A;
Central Nervous System Disorders with Auto-Antibodies in People Living with HIV. in Microorganisms / Microorganisms. 2024 Aug 24;12(9):1758. doi: 10.3390/microorganisms12091758.
2024
ASL Città di Torino
Calcagno A; Trunfio M; Di Perri G; Imperiale D; Stroffolini G; Atzori C;
Studying the Changes in Physical Functioning and Oxidative Stress-Related Molecules in People Living with HIV after Switching from Triple to Dual Therapy. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2024 Apr 26;13(5):518. doi: 10.3390/antiox13050518.
2024
ASL Città di Torino
AOU San Luigi di Orbassano
Rainoldi A; D'Avolio A; Di Perri G; Lupo C; Bonora S; Trevisan G; Cuomo S; Maddalone MG; Tettoni MC; Mula J; Chiara F; Bianco G; Accardo G; Palermiti A; Antonucci M; Ferrara M; Manca A; Mulasso A; Cusato J;
Intermediate dose enoxaparin in hospitalized patients with moderate-severe COVID-19: a pilot phase II single-arm study, INHIXACOVID19. in BMC infectious diseases / BMC Infect Dis. 2023 Oct 24;23(1):718. doi: 10.1186/s12879-023-08297-7.
2023
ASL Città di Torino
Cosmi B; Giannella M; Fornaro G; Cristini F; Patacca A; Castagna A; Mazzaferri F; Testa S; Pan A; Lupi M; Brambilla P; Montineri A; Frattima S; Bignami EG; Salvetti M; De Stefano G; Grandone E; Di Perri G; Rozzini R; Stella A; Romagnoli A; Drago F; Viale P;
Pillars of long-term antiretroviral therapy success. in Pharmacological research / Pharmacol Res. 2023 Oct;196:106898. doi: 10.1016/j.phrs.2023.106898. Epub 2023 Aug 28.
2023
ASL Città di Torino
Taramasso L; Andreoni M; Antinori A; Bandera A; Bonfanti P; Bonora S; Borderi M; Castagna A; Cattelan AM; Celesia BM; Cicalini S; Cingolani A; Cossarizza A; D'Arminio Monforte A; D'Ettorre G; Di Biagio A; Di Giambenedetto S; Di Perri G; Esposito V; Focà E; Gervasoni C; Gori A; Gianotti N; Guaraldi G; Gulminetti R; Lo Caputo S; Madeddu G; Maggi P; Marandola G; et alii...
18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infections. in The Journal of infection / J Infect. 2023 Nov;87(5):462-464. doi: 10.1016/j.jinf.2023.03.013. Epub 2023 Mar 17.
2023
ASL Asti
ASL Città di Torino
Aliberti S; Calcagno A; Di Perri G; Lupia T; Sestini S; Erba PA; Betti M; Botto C; Trezzi M; Venuti F; Penna D; Piccioni P; Gaviraghi A; Stroffolini G;
COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2023 May 20;12(5):1133. doi: 10.3390/antiox12051133.
2023
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; Calcagno A; Bonora S; Di Perri G; Ferrara M; De Vivo ED; Maiese D; Antonucci M; Chiara F; Costanzo M; Mula J; Manca A; Palermiti A; Cusato J;
COVID-19: A Possible Contribution of the MAPK Pathway. in Biomedicines / Biomedicines. 2023 May 16;11(5):1459. doi: 10.3390/biomedicines11051459.
2023
ASL Città di Torino
De Rosa FG; Di Perri G; Ferrara M; Ianniello A; De Vivo ED; Chiara F; Corcione S; Trunfio M; Antonucci M; Costanzo M; Mula J; Palermiti A; Manca A; Cusato J; D'Avolio A; Calcagno A;
Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman. in Virology journal / Virol J. 2023 Jun 13;20(1):123. doi: 10.1186/s12985-023-02086-z.
2023
ASL Città di Torino
Calcagno A; Di Perri G; Fantino S; Alladio F; Burdino E; Allice T; Longo BM; Trevisan G; Ferrara M; Di Girolamo L; Bonora S;
Cerebrospinal Fluid CXCL13 as Candidate Biomarker of Intrathecal Immune Activation, IgG Synthesis and Neurocognitive Impairment in People with HIV. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2023 Jun;18(1-2):169-182. doi: 10.1007/s11481-023-10066-x. Epub 2023 May 11
2023
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Nigra M; Guastamacchia G; Atzori C; Mighetto L; Napoli L; Trunfio M;
Extended and Continuous Infusion of Novel Protected ?-Lactam Antibiotics: A Narrative Review. in Drugs / Drugs. 2023 Jul;83(11):967-983. doi: 10.1007/s40265-023-01893-6. Epub 2023 Jun 14.
2023
ASL Città di Torino
Venuti F; Trunfio M; Martson AG; Lipani F; Audagnotto S; Di Perri G; Calcagno A;
Analytical validation of a novel UHPLC-MS/MS method for 19 antibiotics quantification in plasma: Implementation in a LC-MS/MS Kit. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2023 Jul;163:114790. doi: 10.1016/j.biopha.2023.114790. Epub 2023 Apr 29.
2023
ASL Città di Torino
AOU San Luigi di Orbassano
De Nicolò A; De Rosa FG; Di Perri G; Simiele M; Cusato J; Maiese D; Palermiti A; Manca A; Chiara F; Mula J; D'Avolio A;
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2023 Jan 12;13(2):295. doi: 10.3390/diagnostics13020295.
2023
ASL Città di Torino
D'Avolio A; Bonora S; Mula J; Di Perri G; Manca A; Palermiti A; Marinaro L; Trunfio M; Antonucci M; Avataneo V; Cusato J; Calcagno A;
Seropositivity and reactivations of HSV-1, but not of HSV-2 nor VZV, associate with altered blood-brain barrier, beta amyloid, and tau proteins in people living with HIV. in Journal of neurovirology / J Neurovirol. 2023 Feb;29(1):100-105. doi: 10.1007/s13365-022-01105-z. Epub 2022 Nov 9.
2023
ASL Città di Torino
Atzori C; Di Perri G; Calcagno A; Imperiale D; Burdino E; Russo M; Di Girolamo L; Ponzetta L; Trunfio M;
Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment Regimen. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2023 Dec;18(4):551-562. doi: 10.1007/s11481-023-10086-7. Epub 2023 Oct 31.
2023
ASL Città di Torino
AOU Novara
Calcagno A; Di Perri G G; Bonora S; Nigra M; Trunfio M; Atzori C; Giaccone C; Pirriatore V; Vai D; Barco A; Stroffolini G; Lazzaro A;
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study. in The Lancet regional health. Europe / Lancet Reg Health Eur. 2023 Jul 14;31:100684. doi: 10.1016/j.lanepe.2023.100684. eCollection 2023 Au
2023
ASL Città di Torino
Torti C; Olimpieri PP; Bonfanti P; Tascini C; Celant S; Tacconi D; Nicastri E; Tacconelli E; Cacopardo B; Perrella A; Buccoliero GB; Parruti G; Bassetti M; Biagetti C; Giacometti A; Erne EM; Frontuto M; Lanzafame M; Summa V; Spagnoli A; Vestri A; Di Perri G; Russo P; Palù G;
Pharmacological outlook of Lenacapavir: a novel first-in-class Long-Acting HIV-1 Capsid Inhibitor. in Le infezioni in medicina / Infez Med. 2023 Dec 1;31(4):495-499. doi: 10.53854/liim-3104-8. eCollection 2023.
2023
ASL Città di Torino
Di Perri G;
Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia. in Lung / Lung. 2022 Oct;200(5):573-577. doi: 10.1007/s00408-022-00566-7. Epub 2022 Sep 17.
2022
ASL Città di Torino
Di Perri G; Calcagno A; Cortese G; Bonora S; Traverso F; Nespoli P; Portesani F; Vicinanza S; Trunfio M;
Ceftobiprole and daptomycin concentrations in valve tissue in a patient with mitralic native valve endocarditis. in Journal of chemotherapy (Florence, Italy) / J Chemother. 2022 Oct;34(6):416-418. doi: 10.1080/1120009X.2022.2068850. Epub 2022 Apr 28.
2022
ASL Città di Torino
Boni S; Antonucci M; Manca A; Nicolò A; Martinelli L; Artioli S; Pacini G; Di Perri G; D'Avolio A;
Trichinella britovi outbreak in Piedmont, North-West Italy, 2019-2020: Clinical and epidemiological insights in the one health perspective. in Travel medicine and infectious disease / Travel Med Infect Dis. 2022 May-Jun;47:102308. doi: 10.1016/j.tmaid.2022.102308. Epub 2022 Mar 9.
2022
ASL Asti
ASL Città di Torino
ASL Torino 3
Stroffolini G; Calleri G; Di Perri G; Bonora S; Calcagno A; Paltrinieri G; Lipani F; Lupia T; Faraoni S; Rossi L;
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 May 20;15(5):630. doi: 10.3390/ph15050630.
2022
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; Calcagno A; Rosa FG; Chiara F; Di Perri G; Allegra S; De Francia S; De Nicolò A; Antonucci M; Manca A; Mula J; Palermiti A; Cusato J;
Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 Mar 15;15(3):355. doi: 10.3390/ph15030355.
2022
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Caviglia GP; Mornese Pinna S; Ciancio A; Troshina G; Smedile A; Antonucci M; Avataneo V; Palermiti A; Mula J; Manca A; Cariti G; Cantù M; Saracco GM; Di Perri G; D'Avolio A;
Concurrent and Subsequent Co-Infections of Clostridioides difficile Colitis in the Era of Gut Microbiota and Expanding Treatment Options. in Microorganisms / Microorganisms. 2022 Jun 23;10(7):1275. doi: 10.3390/microorganisms10071275.
2022
ASL Città di Torino
AOU Città della Salute di Torino
Calcagno A; Di Perri G; Bonora S; Rugge W; Scabini S; Trunfio M;
Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV. in AIDS and behavior / AIDS Behav. 2022 Jul;26(7):2203-2211. doi: 10.1007/s10461-021-03563-8. Epub 2022 Jan 4.
2022
ASL Città di Torino
Di Perri G; Calcagno A; Bonora S; Imperiale D; Domini S; Alcantarini C; Milesi M; Medina C; De Francesco D; Vai D; Trunfio M;
Wastewater-based SARS-CoV-2 environmental monitoring for Piedmont, Italy. in Environmental research / Environ Res. 2022 Jan;203:111901. doi: 10.1016/j.envres.2021.111901. Epub 2021 Aug 19.
2022
ARPA Piemonte
ASL Città di Torino
Cusato J; Civra A; Polato D; Brizio E; Quaglino P; Lembo D; Robotto A; Di Perri G;
Seroprevalence of SARS-CoV-2 Among Workers in Northern Italy. in Annals of work exposures and health / Ann Work Expo Health. 2022 Feb 18;66(2):224-232. doi: 10.1093/annweh/wxab062.
2022
ASL Città di Torino
Airoldi C; Calcagno A; Di Perri G; Valinotto R; Gallo L; Locana E; Trunfio M; Patrucco F; Vineis P; Faggiano F;
Obstetric and neonatal outcomes after SARS-CoV-2 infection in the first trimester of pregnancy: A prospective comparative study. in The journal of obstetrics and gynaecology research / J Obstet Gynaecol Res. 2022 Feb;48(2):393-401. doi: 10.1111/jog.15105. Epub 2021 Nov 23.
2022
ASL Città di Torino
Cosma S; Carosso AR; Cusato J; Borella F; Bertero L; Bovetti M; Bevilacqua F; Mengozzi G; Mazzone R; Ghisetti V; Di Perri G; Benedetto C;
Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2022 Dec 16;11(12):1830. doi: 10.3390/antibiotics11121830.
2022
ASL Asti
ASL Città di Torino
AOU Città della Salute di Torino
De Rosa FG; Di Perri G; D'Avolio A; Mula J; Lupia T; Vita D; De Benedetto I; Scabini S; De Nicolò A; Montrucchio G; Mornese Pinna S; Corcione S;
Biofilm Development and Approaches to Biofilm Inhibition by Exopolysaccharides. in The new microbiologica / New Microbiol. 2022 Dec;45(4):227-236. Epub 2022 Oct 3.
2022
ASL Città di Torino
Di Perri G; Ferlazzo G;
Preferences of PLWH and of clinicians for HIV treatment aimed at long-term success. in The new microbiologica / New Microbiol. 2022 Dec;45(4):308-319.
2022
ASL Città di Torino
Corbelli GM; Pasqualetti P; Teti E; Nozza S; Tavio M; Rizzardini G; Mastroianni C; Mussini C; Di Perri G; D'Arminio Monforte A; Castagna A; Antinori A; Andreoni M;
Sex-specific fat mass ratio cutoff value identifies a high prevalence of cardio-metabolic disorders in people living with HIV. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2022 Aug;32(8):1936-1943. doi: 10.1016/j.numecd.2022.05.004. Epub 2022 Ma
2022
ASL Città di Torino
Barale M; Massano M; Bioletto F; Maiorino F; Pusterla A; Mazzetti R; Trentini L; Bonora S; Di Perri G; Ghigo E; Procopio M;
Patterns of Cerebrospinal Fluid Alzheimer's Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition. in Viruses / Viruses. 2022 Apr 4;14(4):753. doi: 10.3390/v14040753.
2022
ASL Città di Torino
Di Perri G; Bonora S; Nigra M; Imperiale D; Vai D; Di Stefano A; Atzori C; Pasquero M; Trunfio M; Calcagno A;
Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders. in Journal of neurovirology / J Neurovirol. 2022 Apr;28(2):226-235. doi: 10.1007/s13365-021-01047-y. Epub 2022 Jan 19.
2022
ASL Città di Torino
Bonora S; Trunfio M; Noce G; Atzori C; Guastamacchia G; Vai D; Lazzaro A; Pirriatore V; Stroffolini G; Orlando S; Barco A; Di Perri G; Calcagno A;
Parietal intrahemispheric source connectivity of resting-state electroencephalographic alpha rhythms is abnormal in Naïve HIV patients. in Brain research bulletin / Brain Res Bull. 2022 Apr;181:129-143. doi: 10.1016/j.brainresbull.2022.01.015. Epub 2022 Jan 29.
2022
ASL Città di Torino
Babiloni C; Del Percio C; Lizio R; Lopez S; Pennica A; Roma P; Correr V; Cucciolla F; Toma G; Soricelli A; Di Campli F; Aceti A; Teti E; Sarmati L; Crocetti G; Ferri R; Lorenzo I; Galli M; Negri C; Angarano G; Saracino A; Lepore L; Di Pietro M; Fusco FM; Vullo V; D'Ettorre G; Pagliano P; Di Flumeri G; Celesia BM; et alii...
Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases. in Frontiers in microbiology / Front Microbiol. 2022 Apr 1;13:829393. doi: 10.3389/fmicb.2022.829393. eCollection 2022.
2022
ASL Città di Torino
Trunfio M; Richiardi L; Alladio F; Staffilano E; Longo B; Venuti F; Ghisetti V; Burdino E; Bonora S; Vineis P; Di Perri G; Calcagno A;
BCGitis after Bacille Calmette-Guerin intravesical administration from two referral centers: clinical characteristics and risk factors. in Le infezioni in medicina / Infez Med. 2022 Jun 1;30(2):242-246. doi: 10.53854/liim-3002-9. eCollection 2022.
2022
ASL Città di Torino
AOU Novara
Di Perri G; Bonora S; Bonfanti P; Lupia T; Lapadula G; Rossi M; Barco A; De Benedetto I; Calcagno A;
Observed concentrations of amikacin and gentamycin in the setting of burn patients with gram-negative bacterial infections: Preliminary data from a prospective study. in Therapie / Therapie. 2021 Sep-Oct;76(5):409-414. doi: 10.1016/j.therap.2020.10.003. Epub 2020 Oct 23.
2021
ASL Città di Torino
AOU Città della Salute di Torino
De Rosa FG; Di Perri G; Stella M; D'Avolio A; Corgiat Loia R; Romeo MR; Pensa A; Lupia T; Segala FV; Corcione S; De Nicolò A;
Seasonal Variation of Antiretroviral Drug Exposure during the Year: The Experience of 10 Years of Therapeutic Drug Monitoring. in Biomedicines / Biomedicines. 2021 Sep 12;9(9):1202. doi: 10.3390/biomedicines9091202.
2021
ASL Città di Torino
Cusato J; Mula J; Palermiti A; Manca A; Antonucci M; Avataneo V; De Vivo ED; Ianniello A; Calcagno A; Di Perri G; De Nicolò A; D'Avolio A;
Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz. in Nutrients / Nutrients. 2021 Oct 12;13(10):3571. doi: 10.3390/nu13103571.
2021
ASL Città di Torino
Cusato J; Tempestilli M; Calcagno A; Vergori A; Piselli P; Antonucci M; Avataneo V; Palermiti A; Notari S; Antinori A; Di Perri G; Agrati C; D'Avolio A;
Alzheimer Dementia in People Living With HIV. in Neurology. Clinical practice / Neurol Clin Pract. 2021 Oct;11(5):e627-e633. doi: 10.1212/CPJ.0000000000001060.
2021
ASL Città di Torino
Di Perri G; Gisslen M; Guaraldi G; d'Ettorre G; Arena V; Imperiale D; Atzori C; Orofino G; Trunfio M; Celani L; Calcagno A;
Serology for Borrelia spp. in Northwest Italy: A Climate-Matched 10-Year Trend. in Life (Basel, Switzerland) / Life (Basel). 2021 Nov 27;11(12):1310. doi: 10.3390/life11121310.
2021
ASL Asti
ASL Città di Torino
Calcagno A; Di Perri G; De Rosa FG; Zanet S; Tomassone L; Rossi L; Faraoni S; Segala FV; Lupia T; Stroffolini G;
Clinical Phenotype and Contagiousness of Early Breakthrough SARS-CoV-2 Infections after BNT162b2 COVID-19 mRNA Vaccine: A Parallel Cohort Study in Healthcare Workers. in Vaccines / Vaccines (Basel). 2021 Nov 23;9(12):1377. doi: 10.3390/vaccines9121377.
2021
ASL Città di Torino
Di Perri G; Bonora S; Emanuele T; Burdino E; Verga F; Ghisetti V; Trunfio M; Calcagno A;
Low cerebrospinal fluid Amyloid-?eta 1-42 in patients with tuberculous meningitis. in BMC neurology / BMC Neurol. 2021 Nov 16;21(1):449. doi: 10.1186/s12883-021-02468-2.
2021
ASL Città di Torino
Calcagno A; Nigra M; Di Stefano A; Di Perri G; Trunfio M; Audagnotto S; Stroffolini G; Atzori C; Guastamacchia G;
Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 May 13;14(5):460. doi: 10.3390/ph14050460.
2021
ASL Città di Torino
De Nicolò A; Manca A; Ianniello A; Palermiti A; Calcagno A; Ferrara M; Antonucci M; Cusato J; Avataneo V; De Vivo E; Bonora S; De Rosa FG; Di Perri G; D'Avolio A;
Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2021 May 12;11(5):867. doi: 10.3390/diagnostics11050867.
2021
ASL Città di Torino
Calcagno A; Di Perri G; Imperiale D; Bonora S; Atzori C; Nigra M; Cusato J; Ghisetti V; Trunfio M; Caligaris G;
Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV. in AIDS (London, England) / AIDS. 2021 May 1;35(6):939-945. doi: 10.1097/QAD.0000000000002853.
2021
ASL Città di Torino
Guaraldi G; Calza S; Milic J; Calcagno A; Focà E; Rota M; Renzetti S; Celotti A; Siano M; Celesia BM; Piconi S; de Socio GV; Cattelan AM; Orofino G; Riva A; Nozza S; di Perri G;
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? in International journal of antimicrobial agents / Int J Antimicrob Agents. 2021 Mar;57(3):106297. doi: 10.1016/j.ijantimicag.2021.106297. Epub 2021 Fe
2021
ASL Città di Torino
Bonora S; Di Perri G; D'Avolio A; Piccioni P; De Nicolò A; Barco A; Rossi G; Costa C; Pirriatore V; Antonucci M; Motta I; Borgogno E; Trentalange A; Calcagno A;
Trend of 25-hydroxycholesterol and 27-hydroxycholesterol plasma levels in patients affected by active chronic hepatitis B virus infection and inactive carriers. in The Journal of steroid biochemistry and molecular biology / J Steroid Biochem Mol Biol. 2021 Jun;210:105854. doi: 10.1016/j.jsbmb.2021.105854. Epub 2021 Feb 22.
2021
ASL Città di Torino
AOU San Luigi di Orbassano
Poli G; Di Perri G; Lembo D; Biasi F; D'Avolio A; Cusato J; Civra A; Boglione L; Caccia C; Leoni V;
The Manifesto of Pharmacoenosis: Merging HIV Pharmacology into Pathocoenosis and Syndemics in Developing Countries. in Microorganisms / Microorganisms. 2021 Jul 31;9(8):1648. doi: 10.3390/microorganisms9081648.
2021
ASL Città di Torino
AOU Città della Salute di Torino
Castelnuovo B; Bonora S; Di Perri G; Pirriatore V; Alcantarini C; Rugge W; Mornese Pinna S; Scabini S; Trunfio M; Calcagno A;
Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases. in The Lancet. Infectious diseases / Lancet Infect Dis. 2021 Jul;21(7):914-915. doi: 10.1016/S1473-3099(21)00205-X. Epub 2021 Apr 14.
2021
ASL Città di Torino
Trunfio M; Calcagno A; Bonora S; Di Perri G;
Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2021 Jan 1;65(1):e01902-20. doi: 10.1128/AAC.01902-20. Epub 2020 Oct 26
2021
ASL Città di Torino
Calcagno A; Dal Conte I; Cattaneo D; Testi R; Mistrangelo M; Gervasoni C; de Nicolò A; Bonora S; D'Avolio A; Di Perri G;
The "scar" of a pandemic: Cumulative incidence of COVID-19 during the first trimester of pregnancy. in Journal of medical virology / J Med Virol. 2021 Jan;93(1):537-540. doi: 10.1002/jmv.26267. Epub 2020 Aug 13.
2021
ASL Città di Torino
Cosma S; Borella F; Carosso A; Sciarrone A; Cusato J; Corcione S; Mengozzi G; Preti M; Katsaros D; Di Perri G; Benedetto C; Cosma S; Borella F; Carosso A; Sciarrone A; Cusato J; Corcione S; Mengozzi G; Preti M; Katsaros D; Di Perri G; Benedetto C;
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV. in Clinical pharmacokinetics / Clin Pharmacokinet. 2021 Jan;60(1):103-109. doi: 10.1007/s40262-020-00916-9.
2021
ASL Città di Torino
Calcagno A; Moltó J; Borghetti A; Gervasoni C; Milesi M; Valle M; Avataneo V; Alcantarini C; Pla-Junca F; Trunfio M; D'Avolio A; Di Giambenedetto S; Cattaneo D; Di Perri G; Bonora S;
Prenatal Biochemical and Ultrasound Markers in COVID-19 Pregnant Patients: A Prospective Case-Control Study. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2021 Feb 26;11(3):398. doi: 10.3390/diagnostics11030398.
2021
ASL Città di Torino
Ghisetti V; Filippini C; Rolfo A; Revelli A; Marozio L; Sciarrone A; Gervasoni F; Carosso M; Bevilacqua F; Bovetti M; Cusato J; Borella F; Carosso AR; Cosma S; Di Perri G; Benedetto C;
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients. in Viruses / Viruses. 2021 Feb 11;13(2):281. doi: 10.3390/v13020281.
2021
ASL Città di Torino
Di Perri G; Bonora S; Picco C; Bertucci R; Ghisetti V; Cerutti F; Burdino E; Longo BM; Alladio F; Venuti F; Trunfio M; Calcagno A;
Co-infection with other respiratory pathogens in COVID-19 patients. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2021 Feb;27(2):297-298. doi: 10.1016/j.cmi.2020.08.012. Epub 2020 Aug 19.
2021
ASL Città di Torino
Boglione L; Bonora S; Allice T; Trunfio M; Burdino E; Ghisetti V; Calcagno A; Di Perri G; Calcagno A; Ghisetti V; Burdino E; Trunfio M; Allice T; Boglione L; Bonora S; Di Perri G;
Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2021 Dec;87(12):4861-4867. doi: 10.1111/bcp.14895. Epub 2021 Jul 4.
2021
ASL Città di Torino
Corcione S; De Nicolò A; Montrucchio G; Scabini S; Avataneo V; Bonetto C; Mornese Pinna S; Cusato J; Canta F; Urbino R; Di Perri G; Brazzi L; De Rosa FG; D'Avolio A;
Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients. in American journal of obstetrics and gynecology / Am J Obstet Gynecol. 2021 Apr;224(4):391.e1-391.e7. doi: 10.1016/j.ajog.2020.10.005. Epub 2020 Oct 8
2021
ASL Città di Torino
Di Perri G; Ghisetti V; D'Avolio A; Filippini C; Bovetti M; Carosso M; Borella F; Cusato J; Carosso AR; Cosma S; Benedetto C; Di Perri G; Ghisetti V; D'Avolio A; Filippini C; Bovetti M; Carosso M; Borella F; Cusato J; Carosso AR; Cosma S; Benedetto C;
Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery. in Journal of reproductive immunology / J Reprod Immunol. 2021 Apr;144:103285. doi: 10.1016/j.jri.2021.103285. Epub 2021 Feb 2.
2021
ASL Città di Torino
Preti M; Ghisetti V; Revelli A; Marozio L; Antonucci M; Borella F; Cusato J; Corcione S; Carosso AR; Cosma S; Di Perri G; Benedetto C;
Preterm birth is not associated with asymptomatic/mild SARS-CoV-2 infection per se: Pre-pregnancy state is what matters. in PloS one / PLoS One. 2021 Aug 5;16(8):e0254875. doi: 10.1371/journal.pone.0254875. eCollection 2021.
2021
ASL Città di Torino
Di Perri G; Ghisetti V; Preti M; Stura I; Gervasoni F; Carosso M; Borella F; Cusato J; Carosso AR; Cosma S; Benedetto C;
On the SARS-CoV-2 "Variolation Hypothesis": No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases. in Frontiers in microbiology / Front Microbiol. 2021 Mar 16;12:646679. doi: 10.3389/fmicb.2021.646679. eCollection 2021.
2021
ASL Città di Torino
Trunfio M; Longo BM; Alladio F; Venuti F; Cerutti F; Ghisetti V; Bonora S; Di Perri G; Calcagno A;
Antiviral Therapy in Patients With Hepatitis B Virus Treated for Tuberculosis: A Forgotten Issue. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2020 Sep 12;71(6):1583-1584. doi: 10.1093/cid/ciz1199.
2020
ASL Città di Torino
Boglione L; Lipani F; Lucchini AM; Salvador E; De Benedetto I; Lupia T; Di Perri G;
Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV. in AIDS (London, England) / AIDS. 2020 Nov 1;34(13):1899-1906. doi: 10.1097/QAD.0000000000002601.
2020
ASL Città di Torino
Calcagno A; Di Perri G; Guastamacchia G; Bonora S; Borgogno E; Domini S; Atzori C; Nigra M; Mighetto L; Vai D; Rugge W; Trunfio M;
Beyond Italian guidelines in the management of HIV-positive patient. in Le infezioni in medicina / Infez Med. 2020 Nov 1;28(4):587-596.
2020
ASL Città di Torino
Andreoni M; Antinori A; Castagna A; D'Arminio Monforte A; Di Perri G; Galli M; Gori A; Mussini C; Perno CF;
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532. Epub 2020 May 1.
2020
ASL Città di Torino
Sciascia S; Aprà F; Baffa A; Baldovino S; Boaro D; Boero R; Bonora S; Calcagno A; Cecchi I; Cinnirella G; Converso M; Cozzi M; Crosasso P; De Iaco F; Di Perri G; Eandi M; Fenoglio R; Giusti M; Imperiale D; Imperiale G; Livigni S; Manno E; Massara C; Milone V; Natale G; Navarra M; Oddone V; Osella S; Piccioni P; et alii...
Presence of Epstein-Barr virus DNA in cerebrospinal fluid is associated with greater HIV RNA and inflammation. in AIDS (London, England) / AIDS. 2020 Mar 1;34(3):373-380. doi: 10.1097/QAD.0000000000002442.
2020
ASL Città di Torino
Di Perri G; Calcagno A; Bonora S; Ghisetti V; Lipani F; Gregori G; Pirriatore V; Mighetto L; Imperiale D; Gianella S; Audagnotto S; Atzori C; Milia MG; Lupia T;
Pharmacokinetics of meropenem in burn patients with infections caused by Gram-negative bacteria: Are we getting close to the right treatment? in Journal of global antimicrobial resistance / J Glob Antimicrob Resist. 2020 Mar;20:22-27. doi: 10.1016/j.jgar.2019.06.011. Epub 2019 Jun 14.
2020
ASL Città di Torino
AOU Città della Salute di Torino
Romeo M; Di Perri G; Stella M; De Rosa FG; Loia RC; Pensa A; Segala FV; De Nicolò A; Fatiguso G; Corcione S; D'Avolio A;
Calcaneal Quantitative Ultrasonography and Urinary Retinol-Binding Protein in Antiretroviral-Treated Patients With Human Immunodeficiency Virus in Uganda: A Pilot Study. in The Journal of infectious diseases / J Infect Dis. 2020 Jun 29;222(2):263-272. doi: 10.1093/infdis/jiaa088.
2020
ASL Città di Torino
Lamorde M; Di Perri G; Mwaka E; Borderi M; Kafufu B; Cusato J; Kasozi W; Kaimal A; Scabini S; Costa C; Calcagno A; Castelnuovo B;
Cerebrospinal fluid biomarkers in patients with central nervous system infections: a retrospective study. in CNS spectrums / CNS Spectr. 2020 Jun;25(3):402-408. doi: 10.1017/S1092852919000981. Epub 2019 May 27.
2020
ASL Città di Torino
Calcagno A; Di Perri G; Mighetto L; Milia MG; Audagnotto S; Imperiale D; Burdino E; Atzori C; Lipani F; Alcantarini C; Di Stefano A;
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2020 Jul 1;75(7):1772-1777. doi: 10.1093/jac/dkaa152.
2020
ASL Città di Torino
Avataneo V; de Nicolò A; Cusato J; Antonucci M; Manca A; Palermiti A; Waitt C; Walimbwa S; Lamorde M; di Perri G; D'Avolio A;
Efficacy and safety of interferon-free regimens in patients affected by chronic hepatitis C and psychiatric disorders. in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy / J Infect Chemother. 2020 Jan;26(1):18-22. doi: 10.1016/j.jiac.2019.06.004. Epub 2019 Jul 10.
2020
ASL Città di Torino
Boglione L; Lupia T; Cariti G; Di Perri G;
Cerebral white matter Hyperintensities in HIV-positive patients. in Brain imaging and behavior / Brain Imaging Behav. 2020 Feb;14(1):10-18. doi: 10.1007/s11682-018-9966-1.
2020
ASL Città di Torino
Di Perri G; Bonora S; Barco A; Nunnari G; Tettoni M; Imperiale D; Cusato J; Prochet A; Trentalange A; Calcagno A;
Plasmatic and intracellular concentration of entecavir during treatment of a symptomatic flare in HBV-HDV decompensated cirrhosis. in Journal of infection and public health / J Infect Public Health. 2020 Feb;13(2):315-316. doi: 10.1016/j.jiph.2019.12.005. Epub 2020 Jan 15.
2020
ASL Città di Torino
De Benedetto I; Boglione L; Salvador E; Lupia T; De Nicolò A; Di Perri G; Lipani F; Lucchini AM;
Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Dec 25;14(1):12. doi: 10.3390/ph14010012.
2020
ASL Città di Torino
De Nicolò A; Ianniello A; Ferrara M; Avataneo V; Cusato J; Antonucci M; De Vivo E; Waitt C; Calcagno A; Trentalange A; Muccioli G; Bonora S; Di Perri G; D'Avolio A;
Tenofovir alafenamide revisited. in Le infezioni in medicina / Infez Med. 2020 Dec 1;28(4):525-533.
2020
ASL Città di Torino
Di Perri G;
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection. in Thrombosis research / Thromb Res. 2020 Dec;196:432-434. doi: 10.1016/j.thromres.2020.09.039. Epub 2020 Oct 8.
2020
ASL Città di Torino
Bonora S; Roccatello D; Sciascia S; Lipani F; Gaviraghi A; Trentalange A; Marinaro L; Alcantarini C; Cabodi D; Salvador E; Trunfio M; Di Perri G; Calcagno A;
Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients. in The pharmacogenomics journal / Pharmacogenomics J. 2020 Apr;20(2):202-212. doi: 10.1038/s41397-019-0109-x. Epub 2019 Oct 16.
2020
ASL Città di Torino
Cusato J; Calcagno A; Marinaro L; Avataneo V; D?Avolio A; Di Perri G; Bonora S;
Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity. in Antiviral therapy / Antivir Ther. 2020;25(6):327-333. doi: 10.3851/IMP3377.
2020
ASL Città di Torino
Trunfio M; Salvador E; Gaviraghi A; Audagnotto S; Marinaro L; Motta I; Casciaro R; Ghisetti V; Fava C; Bonora S; Di Perri G; Calcagno A;
Drug-drug interactions in anti-HCV therapy: a comparison among options available in Italy. in Le infezioni in medicina / Infez Med. 2019 Sep 1;27(3):239-250.
2019
ASL Città di Torino
Di Perri G; Cariti G;
HIV-1 detection in the olfactory mucosa of HIV-1-infected participants. in AIDS (London, England) / AIDS. 2019 Mar 15;33(4):665-674. doi: 10.1097/QAD.0000000000002102.
2019
ASL Città di Torino
Di Perri G; Calcagno A; Bonora S; Amasio E; Zanusso G; Ghisetti V; Pirriatore V; Kincer LP; Imperiale D; Cassoni P; Catera S; Trunfio M; Allice T; Joseph SB; Bertero L;
Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2019 Jun;94(2):202-204. doi: 10.1016/j.diagmicrobio.2018.07.001. Epub 20
2019
ASL Città di Torino
Cusato J; Calcagno A; De Nicolò A; Mogyorosi K; D'Avolio A; Di Perri G; Bonora S;
Antiviral treatment with pegylated interferon and clinical outcomes in a cohort of immigrants patients affected by hepatitis delta: A retrospective analysis. in Journal of medical virology / J Med Virol. 2019 Jul;91(7):1329-1334. doi: 10.1002/jmv.25438. Epub 2019 Mar 4.
2019
ASL Città di Torino
Boglione L; Lupia T; Cariti G; Ghisetti V; Milia MG; Burdino E; Di Perri G;
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab. in Cancers / Cancers (Basel). 2019 Jan 21;11(1):125. doi: 10.3390/cancers11010125.
2019
ASL Città di Torino
Grossi F; Ferlazzo G; Boccardo S; Dal Bello MG; Coco S; Di Perri G; Leggieri A; Rijavec E; Cossu I; Pietra G; Mingari MC; Ottonello S; Tomasello C; Carrega P; D'Avolio A; Genova C; Cusato J;
Clinical pharmacology of the single tablet regimen bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF). in Le infezioni in medicina / Infez Med. 2019 Dec 1;27(4):365-373.
2019
ASL Città di Torino
Di Perri G;
ERRATUM Drug-drug interactions in anti-HCV therapy: a comparison among options available in Italy. in Le infezioni in medicina / Infez Med. 2019 Dec 1;27(4):481.
2019
ASL Città di Torino
Di Perri G; Cariti G;
The "milky way" galaxy of HIV-related central nervous system immune reaction syndromes. in Journal of neurovirology / J Neurovirol. 2019 Dec;25(6):887-892. doi: 10.1007/s13365-019-00769-4. Epub 2019 Jun 18.
2019
ASL Città di Torino
Di Perri G; Taraglio S; Bonora S; Imperiale D; Audagnotto S; Boghi A; Trentalange A; Manini C; Trunfio M; Calcagno A;
Malignant Melanoma in People Living with HIV/AIDS: Can We Know More, Can We Do Better? in AIDS reviews / AIDS Rev. 2019;21(2):65-75. doi: 10.24875/AIDSRev.19000038.
2019
ASL Città di Torino
Trunfio M; Ribero S; Bonora S; Di Perri G; Quaglino P; Calcagno A;
Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort. in PloS one / PLoS One. 2019 Oct 17;14(10):e0222225. doi: 10.1371/journal.pone.0222225. eCollection 2019.
2019
ASL Città di Torino
Focà E; Magro P; Guaraldi G; Riva A; Cattelan AM; De Socio GV; Costa C; Piconi S; Celesia BM; Nozza S; Orofino G; Castagna A; Di Perri G; Castelli F; Calcagno A;
Flecainide plasma level modifications during ledipasvir/sofosbuvir coadministration in two patients affected by chronic hepatitis C. in Antiviral therapy / Antivir Ther. 2019;24(7):553-555. doi: 10.3851/IMP3328.
2019
ASL Città di Torino
Boglione L; De Nicolò A; Di Perri G; D'Avolio A;
A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples. in Journal of pharmacological and toxicological methods / J Pharmacol Toxicol Methods. 2018 Nov-Dec;94(Pt 2):29-35. doi: 10.1016/j.vascn.2018.08.003. Epub 201
2018
ASL Città di Torino
AOU Città della Salute di Torino
Di Perri G; Veglio F; Mulatero P; Favata F; Allegra S; Fatiguso G; Perlo E; Cusato J; Tosello F; Sciandra M; Rabbia F; Avataneo V; De Nicolò A; D'Avolio A; Avataneo V; De Nicolò A; Rabbia F; Sciandra M; Tosello F; Cusato J; Perlo E; Fatiguso G; Allegra S; Favata F; Mulatero P; Veglio F; Di Perri G; D'Avolio A;
Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Nov;84(11):2535-2543. doi: 10.1111/bcp.13706. Epub 2018 Aug 15.
2018
ASL Città di Torino
AOU Città della Salute di Torino
D'Avolio A; Cusato J; Pappaccogli M; Berra E; Burrello J; Perlo E; Rabbia F; De Nicolò A; Avataneo V; Di Perri G; Veglio F; Avataneo V; De Nicolò A; Rabbia F; Perlo E; Burrello J; Berra E; Pappaccogli M; Cusato J; D'Avolio A; Di Perri G; Veglio F;
Diagnostic accuracy of new and old cognitive screening tools for HIV-associated neurocognitive disorders. in HIV medicine / HIV Med. 2018 May 15. doi: 10.1111/hiv.12622.
2018
ASL Città di Torino
Di Perri G; Imperiale D; Bonora S; Audagnotto S; Orofino G; Tettoni MC; Livelli A; Alcantarini C; Vai D; Montrucchio C; Trunfio M; Calcagno A;
Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 2018 Mar;81(3):615-620. doi: 10.1007/s00280-018-3520-0. Epub 2018 Jan 22
2018
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Cantù M; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Jun 1;73(6):1659-1664. doi: 10.1093/jac/dky053.
2018
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;
Antiviral activity of maraviroc plus mirtazapine in a low-risk HIV-negative patient with progressive multifocal leukoencephalopathy. in Le infezioni in medicina / Infez Med. 2018 Jun 1;26(2):160-163.
2018
ASL Città di Torino
Perna M; Cistaro A; Cinnirella G; Ghisetti V; Bertucci R; Audagnotto S; Imperiale D; Pirriatore V; Trunfio M; Scabini S; Calcagno A; Di Perri G;
Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy. in Pharmacogenomics / Pharmacogenomics. 2018 Jun 1;19(8):701-707. doi: 10.2217/pgs-2018-0009. Epub 2018 May 23.
2018
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Pinna SM; Carcieri C; Guido F; Cariti G; Di Perri G; D'Avolio A;
Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2018 Jun;60:42-47. doi: 10.1016/j.meegid.2018.02.016. Epub 2018 Feb 13.
2018
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;
Extended duration of treatment with peginterferon alfa-2a in patients with chronic hepatitis B, HBeAg-negative and E genotype: A retrospective analysis. in Journal of medical virology / J Med Virol. 2018 Jun;90(6):1047-1052. doi: 10.1002/jmv.25038. Epub 2018 Mar 15.
2018
ASL Città di Torino
Boglione L; Cariti G; Ghisetti V; Burdino E; Di Perri G;
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Jan;84(1):197-203. doi: 10.1111/bcp.13401. Epub 2017 Sep 24.
2018
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; Di Perri G; De Nicolò A; Cusato J; Pirro E; Carcieri C; De Francia S; Favata F; Fatiguso G; Allegra S; Allegra S; Fatiguso G; De Francia S; Favata F; Pirro E; Carcieri C; De Nicolò A; Cusato J; Di Perri G; D'Avolio A;
Cannabinoids concentration variability in cannabis olive oil galenic preparations. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2018 Jan;70(1):143-149. doi: 10.1111/jphp.12845. Epub 2017 Oct 23.
2018
ASL Città di Torino
AOU San Luigi di Orbassano
Di Perri G; Canzoneri L; Cusato J; Avataneo V; De Nicolò A; Simiele M; Tomasello C; D'Avolio A; Carcieri C; Carcieri C; Tomasello C; Simiele M; De Nicolò A; Avataneo V; Canzoneri L; Cusato J; Di Perri G; D'Avolio A;
Undetectable antimicrobial plasma concentrations in an HIV-positive patient with protein-losing enteropathy and chylothorax during Mycobacterium genavense and Leishmania abdominal infections. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Feb 1;73(2):546-548. doi: 10.1093/jac/dkx385.
2018
ASL Città di Torino
Motta I; Trunfio M; Calcagno A; Pirriatore V; Scabini S; Palazzo A; Audagnotto S; Fatiguso G; Liberini V; Bellò M; D'Avolio A; Di Perri G; Bonora S;
Symptomatic cerebrospinal fluid HIV-1 escape with no resistance-associated mutations following low-level plasma viremia. in Journal of neurovirology / J Neurovirol. 2018 Feb;24(1):132-136. doi: 10.1007/s13365-017-0605-1. Epub 2017 Dec 14.
2018
ASL Città di Torino
AOU San Luigi di Orbassano
Calcagno A; Trunfio M; Imperiale D; Di Perri G; Sala A; Ferrara M; Audagnotto S; Pesci Kincer L; Cusato J; Martini C; Joseph SB; Ghisetti V; Romito A; Trunfio M; Joseph SB; Ghisetti V; Romito A; Martini C; Cusato J; Audagnotto S; Pesci Kincer L; Ferrara M; Sala A; Imperiale D; Di Perri G; Calcagno A;
Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations. in Journal of clinical pharmacology / J Clin Pharmacol. 2018 Dec;58(12):1550-1556. doi: 10.1002/jcph.1266. Epub 2018 Jun 6.
2018
ASL Città di Torino
Allegra S; Cardellino CS; Fatiguso G; Cusato J; De Nicolò A; Avataneo V; Bonora S; D'Avolio A; Di Perri G; Calcagno A;
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years. in BMC geriatrics / BMC Geriatr. 2018 Apr 20;18(1):99. doi: 10.1186/s12877-018-0789-0.
2018
ASL Città di Torino
Guaraldi G; Malagoli A; Calcagno A; Mussi C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Riva A; Focà E; Nozza S; Di Perri G;
Current and future challenges in HCV: insights from an Italian experts panel. in Infection / Infection. 2018 Apr;46(2):147-163. doi: 10.1007/s15010-017-1093-1. Epub 2017 Nov 2.
2018
ASL Città di Torino
Andreoni M; Babudieri S; Bruno S; Colombo M; Zignego AL; Di Marco V; Di Perri G; Perno CF; Puoti M; Taliani G; Villa E; Craxì A;
Laboratory findings in Zika infection: The experience of a reference centre in North-West Italy. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2018 Apr;101:18-22. doi: 10.1016/j.jcv.2018.01.010. Epub 2018 Jan 31.
2018
ASL Città di Torino
Burdino E; Milia MG; Allice T; Gregori G; Ruggiero T; Calleri G; Lipani F; Lucchini A; Venturi G; Di Perri G; Ghisetti V;
Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens. in Archives of virology / Arch Virol. 2018 Apr;163(4):961-967. doi: 10.1007/s00705-017-3684-7. Epub 2018 Jan 9.
2018
ASL Città di Torino
Boglione L; Cusato J; Pinna SM; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;
Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessment. in The new microbiologica / New Microbiol. 2018 Apr;41(2):112-117.
2018
ASL Città di Torino
Borderi M; Angarano G; Antinori A; Chirianni A; Cinque P; D'Arminio Monforte A; Di Biagio A; Di Perri G; Galli M; Gori A; Lazzarin A; Mussini C; Perno CF; Quirino T; Rizzardini G; Calza L; Viale P; Acone B; Andreoni M;
The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment. in Antiviral therapy / Antivir Ther. 2018;23(5):451-456. doi: 10.3851/IMP3221.
2018
ASL Città di Torino
Bigliano P; Calcagno A; Lucchini A; Audagnotto S; Montrucchio C; Marinaro L; Alcantarini C; Ghisetti V; Di Perri G; Bonora S;
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients. in PloS one / PLoS One. 2018 Feb 20;13(2):e0192627. doi: 10.1371/journal.pone.0192627. eCollection 2018.
2018
ASL Città di Torino
Taramasso L; Di Biagio A; Bovis F; Nicolini LA; Antinori A; Milazzo L; Sollima S; Gubertini G; Niero F; Saracino A; Bruno R; Borghi V; Montagnani F; Cattelan A; Hasson H; Taliani G; D'Arminio Monforte A; Mastroianni C; Di Perri G; Bigoni S; Puoti M; Spinetti A; Gori A; Boffa N; Cacopardo B; Giacometti A; Parruti G; Vullo V; Chirianni A; et alii...
Correlation between entecavir penetration in peripheral blood mononuclear cells and HBV DNA decay during treatment of HBeAg-negative chronic hepatitis B. in Antiviral therapy / Antivir Ther. 2018;23(4):373-377. doi: 10.3851/IMP3207.
2018
ASL Città di Torino
De Nicolò A; Boglione L; Cusato J; Fatiguso G; Favata F; Allegra S; Cariti G; Di Perri G; D'Avolio A;
Retreatment with sofosbuvir/velpatasvir in cirrhotic patients with genotype-4 who failed a previous interferon-free regimen: a case series. in Antiviral therapy / Antivir Ther. 2018;23(6):543-547. doi: 10.3851/IMP3226.
2018
ASL Città di Torino
Boglione L; Pinna SM; Lupia T; Cariti G; Di Perri G;
The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin-induced anaemia in chronic hepatitis C Egyptian patients. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Sep;44(9):965-968. doi: 10.1111/1440-1681.12786.
2017
ASL Città di Torino
El Desoky ES; Abdelhafez AT; Cusato J; Kamel SI; Hussein AM; De Nicolo A; Di Perri G; D'Avolio A;
Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis C. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2017 Sep;53:195-198. doi: 10.1016/j.meegid.2017.05.026. Epub 2017 Jun 1.
2017
ASL Città di Torino
Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;
A simple high performance liquid chromatography-mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 Oct 25;145:718-724. doi: 10.1016/j.jpba.2017.07.040. Epub 2017 Aug 5.
2017
ASL Città di Torino
Fatiguso G; Favata F; Zedda I; De Nicolò A; Cusato J; Avataneo V; Di Perri G; D'Avolio A;
Reasons to wait or to treat naive patients affected by chronic hepatitis C with low fibrosis stage and genotypes 2 or 3. in European journal of public health / Eur J Public Health. 2017 Oct 1;27(5):938-941. doi: 10.1093/eurpub/ckx025.
2017
ASL Città di Torino
Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;
Influence of ABCB11 and HNF4? genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Oct 1;72(10):2846-2849. doi: 10.1093/jac/dkx237.
2017
ASL Città di Torino
Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study. in Journal of viral hepatitis / J Viral Hepat. 2017 Oct;24(10):850-857. doi: 10.1111/jvh.12711. Epub 2017 Apr 25.
2017
ASL Città di Torino
Boglione L; Mornese Pinna S; De Nicolò A; Cusato J; Cariti G; Di Perri G; D'Avolio A;
Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy? in Journal of neurovirology / J Neurovirol. 2017 Oct;23(5):763-767. doi: 10.1007/s13365-017-0549-5. Epub 2017 Jul 5.
2017
ASL Città di Torino
Di Perri G; Bonora S; Lipani F; Prochet A; Audagnotto S; Ghisetti V; Imperiale D; Milia MG; Scarvaglieri E; Mornese Pinna S; Calcagno A;
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection. in Biomedicines / Biomedicines. 2017 Nov 20;5(4):66. doi: 10.3390/biomedicines5040066.
2017
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; Di Perri G; Cusato J; Pirro E; Carcieri C; De Nicolò A; Favata F; De Francia S; Fatiguso G; Allegra S;
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Nov;44(11):1083-1088. doi: 10.1111/1440-1681.12822. Epub 2017 Sep 5
2017
ASL Città di Torino
AOU San Luigi di Orbassano
D'Avolio A; Di Perri G; De Nicolò A; Cusato J; Carcieri C; De Francia S; Favata F; Pirro E; Fatiguso G; Allegra S;
UPLC-MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 May 10;138:223-230. doi: 10.1016/j.jpba.2017.02.002. Epub 2017 Feb 3.
2017
ASL Città di Torino
Simiele M; Ariaudo A; De Nicolò A; Favata F; Ferrante M; Carcieri C; Bonora S; Di Perri G; De Avolio A;
Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):607-611. doi: 10.2217/pgs-2016-0040. Epub 2017 Apr 28.
2017
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Cardellino CS; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patients. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):651-661. doi: 10.2217/pgs-2016-0041. Epub 2017 Apr 28.
2017
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Imbornone R; Cardellino CS; Ghisetti V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Pharmacogenomic influence on sepsis outcome in critically ill patients. in Le infezioni in medicina / Infez Med. 2017 Mar 1;25(1):45-49.
2017
ASL Città di Torino
Allegra S; Fatiguso G; Baietto L; Corcione S; Favata F; Ariaudo A; Pagani N; Ranieri VM; De Rosa FG; Di Perri G; D'Avolio A;
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2017 Mar 1;64(5):680-683. doi: 10.1093/cid/ciw846. Epub 2016 Dec 22.
2017
ASL Città di Torino
Massimo A; Teti E; Antinori A; Milazzoi L; Sollima S; Rizzardini G; Di Biagio A; Saracino A; Bruno R; Borghi V; De Luca A; Cattelan A; Hasson H; Taliani G; Monforte AD; Mastroianni CM; Di Perri G; Bigoni S; Puoti M; Spinetti A; Gori A; Boffa N; Bruno C; Giacometti A; Parruti G; Vullo V; Chirianni A; Pennica A; Pasquazzi C; et alii...
First UHPLC-MS/MS method coupled with automated online SPE for quantification both of tacrolimus and everolimus in peripheral blood mononuclear cells and its application on samples from co-treated pediatric patients. in Journal of mass spectrometry : JMS / J Mass Spectrom. 2017 Mar;52(3):187-195. doi: 10.1002/jms.3909.
2017
ASL Città di Torino
AOU Città della Salute di Torino
Tandoi F; Romagnoli R; Nonnato A; Calvo PL; Pisciotta C; De Nicolò A; Pinon M; Pensi D; Di Perri G; D'Avolio A;
Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2017 Mar;12(1):187-193. doi: 10.1007/s11481-016-9717-2. Epub 2016 Nov 8.
2017
ASL Città di Torino
Di Perri G; Imperiale D; Lipani F; Scarvaglieri E; Audagnotto S; Cardellino C; Ghisetti V; Atzori C; Romito A; Calcagno A; Bonora S;
Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics. in Pharmacogenomics / Pharmacogenomics. 2017 Jun;18(9):865-880. doi: 10.2217/pgs-2017-0176. Epub 2017 Jun 8.
2017
ASL Città di Torino
Allegra S; Fatiguso G; Calcagno A; Baietto L; Motta I; Favata F; Cusato J; Bonora S; Di Perri G; D'Avolio A;
Role of simeprevir plasma concentrations in HCV treated patients with dermatological manifestations. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2017 Jun;49(6):705-708. doi: 10.1016/j.dld.2017.01.144. Epub 2017 Jan 17.
2017
ASL Città di Torino
Boglione L; De Nicolò A; Mornese Pinna S; Cusato J; Favata F; Ariaudo A; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Pharmacokinetics of linezolid in critically ill patients: impact of continuous venovenous haemofiltration. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2017 Jun;49(6):784-785. doi: 10.1016/j.ijantimicag.2017.04.002. Epub 2017 A
2017
ASL Città di Torino
Corcione S; D'Avolio A; Allegra S; Fanelli V; Urbino R; Ranieri MV; Di Perri G; De Rosa FG;
Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2017 Jul;51:167-172. doi: 10.1016/j.meegid.2017.03.014. Epub 2017 Mar 16.
2017
ASL Città di Torino
Boglione L; Cardellino CS; Cusato J; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;
Pharmacokinetics of colistin methanesulfonate (CMS) in burn patients. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Jan;72(1):319-321. doi: 10.1093/jac/dkw361. Epub 2016 Sep 2.
2017
ASL Città di Torino
Corcione S; Baietto L; Malvasio V; Stella M; Di Perri G; D'Avolio A; De Rosa FG;
Treating HIV Infection in the Central Nervous System. in Drugs / Drugs. 2017 Feb;77(2):145-157. doi: 10.1007/s40265-016-0678-9.
2017
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S;
Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2017 Feb;87:30-36. doi: 10.1016/j.jcv.2016.11.015. Epub 2016 Dec 1.
2017
ASL Città di Torino
Marinaro L; Calcagno A; Ripamonti D; Cenderello G; Pirriatore V; Trentini L; Salassa B; Bramato C; Orofino G; D'Avolio A; Rizzi M; Di Perri G; Rusconi S; Bonora S;
Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors. in Infection / Infection. 2017 Feb;45(1):103-106. doi: 10.1007/s15010-016-0962-3. Epub 2016 Nov 16.
2017
ASL Città di Torino
Boglione L; Pinna SM; Cardellino CS; De Nicolò A; Cusato J; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 Aug 5;142:279-285. doi: 10.1016/j.jpba.2017.05.018. Epub 2017 May 13.
2017
ASL Città di Torino
AOU Città della Salute di Torino
D'Avolio A; Di Perri G; Veglio F; Mulatero P; Perlo E; Cusato J; Tosello F; Sciandra M; Rabbia F; De Nicolò A; Avataneo V; De Nicolò A; Avataneo V; Rabbia F; Sciandra M; Tosello F; Cusato J; Perlo E; Mulatero P; Veglio F; Di Perri G; D'Avolio A;
Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia. in Antiviral therapy / Antivir Ther. 2017;22(6):539-543. doi: 10.3851/IMP3140. Epub 2017 Feb 15.
2017
ASL Città di Torino
Bonora S; Di Perri G; Ghisetti V; Imperiale D; Ecclesia S; Ferrara M; Romito A; Allice T; Motta I; Calcagno A;
High Incidence of Infections in HIV-positive Patients Treated for Lymphoproliferative Disorders. in Current HIV research / Curr HIV Res. 2017;15(4):258-265. doi: 10.2174/1570162X15666170531085838.
2017
ASL Città di Torino
Calcagno A; Lucchini A; Caracciolo D; Balbiano R; Bracchi M; Sordella F; Gregori G; Lipani F; Audagnotto S; Chiriotto M; Cavaglia G; Ghisetti V; Di Perri G; Bonora S;
UHPLC-MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Sep 10;129:535-541. doi: 10.1016/j.jpba.2016.07.049. Epub 2016 Aug 1.
2016
ASL Città di Torino
AOU Città della Salute di Torino
Di Perri G; Veglio F; Mulatero P; Perlo E; Tomasello C; Cusato J; Bonifacio G; Rabbia F; Avataneo V; De Nicolò A; D'Avolio A;
Entecavir plasma concentrations are inversely related to HBV-DNA decrease in a cohort of treatment-naïve patients with chronic hepatitis B. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2016 Sep;48(3):324-7. doi: 10.1016/j.ijantimicag.2016.05.016. Epub 2016 Jul
2016
ASL Città di Torino
Boglione L; De Nicolò A; Cusato J; Bonifacio G; Cariti G; Di Perri G; D'Avolio A;
Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90?mg in a patient with severe epilepsy on oxcarbazepine. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2016 Sep;48(3):347-8. doi: 10.1016/j.ijantimicag.2016.07.002. Epub 2016 Aug
2016
ASL Città di Torino
Smolders EJ; de Kanter CT; van 't Veer N; D'avolio A; Di Perri G; Burger DM; van Wijngaarden P;
The role of tenofovir alafenamide in future HIV management. in HIV medicine / HIV Med. 2016 May;17 Suppl 2:4-16. doi: 10.1111/hiv.12401.
2016
ASL Città di Torino
Antela A; Aguiar C; Compston J; Hendry BM; Boffito M; Mallon P; Pourcher-Martinez V; Di Perri G;
Sequential therapy with entecavir and peginterferon alpha in chronic hepatitis B: for many but not for all? in Journal of viral hepatitis / J Viral Hepat. 2016 May;23(5):402-3. doi: 10.1111/jvh.12502. Epub 2016 Feb 3.
2016
ASL Città di Torino
Boglione L; Cariti G; Di Perri G; D'Avolio A;
A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Jun 5;125:369-75. doi: 10.1016/j.jpba.2016.04.031. Epub 2016 Apr 20.
2016
ASL Città di Torino
Ariaudo A; Favata F; De Nicolò A; Simiele M; Paglietti L; Boglione L; Cardellino CS; Carcieri C; Di Perri G; D'Avolio A;
Sixty milligram daclatasvir is the right dose for hepatitis C virus treatment in combination with etravirine and darunavir/ritonavir. in AIDS (London, England) / AIDS. 2016 Jun 1;30(9):1491-3. doi: 10.1097/QAD.0000000000001089.
2016
ASL Città di Torino
Smolders EJ; Kanter CT; Grintjes K; D'Avolio A; Di Perri G; van Crevel R; Drenth JP; Burger DM;
Pharmacogenetics of ribavirin-induced anemia in HCV patients. in Pharmacogenomics / Pharmacogenomics. 2016 Jun;17(8):925-41. doi: 10.2217/pgs.16.22. Epub 2016 Jun 1.
2016
ASL Città di Torino
D'Avolio A; Cusato J; De Nicolò A; Allegra S; Di Perri G;
Risk factors for mortality in patients with Staphylococcus aureus bloodstream infection. in Journal of chemotherapy (Florence, Italy) / J Chemother. 2016 Jun;28(3):187-90. doi: 10.1179/1973947815Y.0000000076. Epub 2016 May 30.
2016
ASL Città di Torino
De Rosa FG; Corcione S; Motta I; Petrolo A; Filippini C; Pagani N; Fossati L; Cavallo R; Di Perri G;
Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemia. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2016 Jun;26(6):307-10. doi: 10.1097/FPC.0000000000000223.
2016
ASL Città di Torino
Cusato J; Boglione L; De Nicolò A; Cardellino CS; Carcieri C; Cariti G; Di Perri G; D'Avolio A;
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy. in HIV medicine / HIV Med. 2016 Jun;17(6):471-8. doi: 10.1111/hiv.12344. Epub 2015 Nov 26.
2016
ASL Città di Torino
Babiker A; Rockstroh J; Tellez MJ; Di Perri G; Williams I; Amieva H; Cabié A; Llibre JM; Arenas-Pinto A; Antinori A; Stöhr W; Winston A; Pozniak A; Raffi F; Richert L;
UHPLC-MS/MS method with automated on-line solid phase extraction for the quantification of entecavir in peripheral blood mononuclear cells of HBV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Jan 25;118:64-69. doi: 10.1016/j.jpba.2015.10.017. Epub 2015 Oct 22.
2016
ASL Città di Torino
Di Perri G; Tomasello C; Pensi D; Cusato J; Boglione L; Bonifacio G; De Nicolò A; D'Avolio A; De Nicolò A; Bonifacio G; Boglione L; Cusato J; Pensi D; Tomasello C; Di Perri G; D'Avolio A;
Efavirenz pharmacogenetics in a cohort of Italian patients. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2016 Feb;47(2):117-23. doi: 10.1016/j.ijantimicag.2015.11.012. Epub 2015 De
2016
ASL Città di Torino
Di Perri G; Leggieri A; Allegra S; Marinaro L; Bonora S; Calcagno A; Simiele M; Tomasello C; Cusato J; D'Avolio A; Cusato J; Tomasello C; Simiele M; Calcagno A; Bonora S; Marinaro L; Leggieri A; Allegra S; Di Perri G; D'Avolio A;
Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients. in Journal of neurovirology / J Neurovirol. 2016 Feb;22(1):88-92. doi: 10.1007/s13365-015-0371-x. Epub 2015 Aug 6.
2016
ASL Città di Torino
Di Perri G; Imperiale D; Montrucchio C; Stella ML; Vai D; Audagnotto S; Romito A; Atzori C; Calcagno A; Bonora S; Calcagno A; Atzori C; Romito A; Vai D; Audagnotto S; Stella ML; Montrucchio C; Imperiale D; Di Perri G; Bonora S;
Role of HBsAg decline in patients with chronic hepatitis B HBeAg-negative and E genotype treated with pegylated-interferon. in Antiviral research / Antiviral Res. 2016 Dec;136:32-36. doi: 10.1016/j.antiviral.2016.10.011. Epub 2016 Oct 26.
2016
ASL Città di Torino
Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;
HCV NS3 naturally occurring variants in HIV/HCV coinfected DAA-naïve patients: consideration for HCV genotyping resistance testing. in Infection / Infection. 2016 Dec;44(6):789-792. doi: 10.1007/s15010-016-0937-4. Epub 2016 Aug 13.
2016
ASL Città di Torino
Ruggiero T; Burdino E; Calcagno A; Bonora S; Boglione L; Di Perri G; Ghisetti V;
Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients. in Drugs / Drugs. 2016 Aug;76(12):1161-74. doi: 10.1007/s40265-016-0610-3.
2016
ASL Città di Torino
D'Avolio A; Pensi D; Baietto L; Pacini G; Di Perri G; De Rosa FG;
Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics. in Current HIV research / Curr HIV Res. 2016;14(1):54-60. doi: 10.2174/1570162x13666150929112135.
2016
ASL Città di Torino
Calcagno A; Montrucchio C; Capetti A; Guaraldi G; Cenderello G; Calza L; Lanzafame M; Marinaro L; Tettoni MC; Trentini L; D'Avolio A; Di Perri G; Bonora S;
The Role of IL28B Genotype in HCV-RNA Baseline Levels. in Intervirology / Intervirology. 2016;59(2):67-68. doi: 10.1159/000448332. Epub 2016 Sep 8.
2016
ASL Città di Torino
Boglione L; Cusato J; Di Perri G; D'Avolio A;
A Possible Role of Therapeutic Drug Monitoring in Virological Breakthrough during Simeprevir and PEG-IFN Treatment in HCV-4. in Intervirology / Intervirology. 2016;59(5-6):283-284. doi: 10.1159/000477809. Epub 2017 Jun 22.
2016
ASL Città di Torino
Boglione L; Ruggiero T; De Nicolò A; D'Avolio A; Di Perri G;
Start Smart With Antimicrobial Stewardship. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2015 Sep 15;61(6):1033-4. doi: 10.1093/cid/civ458. Epub 2015 Jun 10.
2015
ASL Città di Torino
Corcione S; Pagani N; Forni N; Di Perri G; De Rosa FG;
Development and validation of an ultra performance liquid chromatography tandem mass method for sildenafil and N-desmethyl sildenafil plasma determination and quantification. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Sep 15;1001:35-40. doi: 10.1016/j.jchromb.2015.0
2015
ASL Città di Torino
AOU Città della Salute di Torino
Ranieri VM; D'Avolio A; Di Perri G; Rinaldi M; Ivaldi F; Pasero D; Pensi D; Simiele M;
A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Sep;70(9):2572-5. doi: 10.1093/jac/dkv148. Epub 2015 Jun 11.
2015
ASL Città di Torino
Baietto L; Calcagno A; Motta I; Baruffi K; Poretti V; Di Perri G; Bonora S; D'Avolio A;
Wound botulism after traumatic open fracture in Italy. in Le infezioni in medicina / Infez Med. 2015 Sep;23(3):280-2.
2015
ASL Città di Torino
De Rosa FG; Stella ML; Astegiano S; Corcione S; Motta I; Decastelli L; Di Perri G;
A LC-MS method to quantify tenofovir urinary concentrations in treated patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Oct 10;114:8-11. doi: 10.1016/j.jpba.2015.05.001. Epub 2015 May 8.
2015
ASL Città di Torino
Simiele M; Carcieri C; De Nicolò A; Ariaudo A; Sciandra M; Calcagno A; Bonora S; Di Perri G; D'Avolio A;
UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Oct 10;114:127-32. doi: 10.1016/j.jpba.2015.05.016. Epub 2015 May 22.
2015
ASL Città di Torino
De Nicolò A; Simiele M; Pensi D; Boglione L; Allegra S; Di Perri G; D'Avolio A;
Ageing with HIV: a multidisciplinary review. in Infection / Infection. 2015 Oct;43(5):509-22. doi: 10.1007/s15010-015-0795-5. Epub 2015 May 19.
2015
ASL Città di Torino
Calcagno A; Nozza S; Muss C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Ripamonti D; Riva A; Di Perri G;
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project. in The new microbiologica / New Microbiol. 2015 Oct;38(4):443-90.
2015
ASL Città di Torino
Andreoni M; Marcotullio S; Puro V; De Carli G; Tambussi G; Nozza S; Gori A; Rusconi S; Santoro MM; Clementi M; Perno CF; d'Arminio Monforte A; Maggiolo F; Castagna A; De Luca A; Galli M; Giacomelli A; Borderi M; Guaraldi G; Calcagno A; Di Perri G; Bonora S; Mussini C; Di Biagio A; Puoti M; Bruno R; Zuccaro V; Antinori A; Cinque P; et alii...
HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated Patients. in AIDS research and human retroviruses / AIDS Res Hum Retroviruses. 2015 Oct;31(10):999-1008. doi: 10.1089/AID.2015.0102. Epub 2015 Aug 6.
2015
ASL Città di Torino
Calcagno A; Motta I; Ghisetti V; Lo Re S; Allice T; Marinaro L; Milia MG; Tettoni MC; Trentini L; Orofino G; Salassa B; Di Perri G; Bonora S;
Erratum to: Ageing with HIV: a multidisciplinary review. in Infection / Infection. 2015 Oct;43(5):627. doi: 10.1007/s15010-015-0808-4.
2015
ASL Città di Torino
Calcagno A; Nozza S; Mussi C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Ripamonti D; Riva A; Di Perri G;
UPLC-MS/MS method with automated on-line SPE for the isomer-specific quantification of the first-generation anti-HCV protease inhibitors in peripheral blood mononuclear cells. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Nov 10;115:443-9. doi: 10.1016/j.jpba.2015.08.004. Epub 2015 Aug 4.
2015
ASL Città di Torino
De Nicolò A; Abdi AM; Boglione L; Baiett L; Allegra S; Di Perri G; D'Avolio A;
Class-specific relative genetic contribution for key antiretroviral drugs. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Nov;70(11):3074-9. doi: 10.1093/jac/dkv207. Epub 2015 Jul 28.
2015
ASL Città di Torino
Siccardi M; Olagunju A; Simiele M; D'Avolio A; Calcagno A; Di Perri G; Bonora S; Owen A;
Pharmacokinetics of high dosage of linezolid in two morbidly obese patients-authors' response. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Nov;70(11):3169. doi: 10.1093/jac/dkv240. Epub 2015 Aug 5.
2015
ASL Città di Torino
Corcione S; Pagani N; Baietto L; Fanelli V; Urbino R; Ranieri VM; Di Perri G; D'Avolio A; De Rosa FG;
Predominance of hepatitis C virus Q80K among NS3 baseline-resistance-associated amino acid variants in direct-antiviral-agent-naïve patients with chronic hepatitis: single-centre experience. in Archives of virology / Arch Virol. 2015 Nov;160(11):2881-5. doi: 10.1007/s00705-015-2563-3. Epub 2015 Aug 7.
2015
ASL Città di Torino
Ruggiero T; Proietti A; Boglione L; Milia MG; Allice T; Burdino E; Orofino G; Bonora S; Di Perri G; Ghisetti V;
An UPLC-MS/MS method coupled with automated on-line SPE for quantification of tacrolimus in peripheral blood mononuclear cells. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Mar 25;107:512-7. doi: 10.1016/j.jpba.2015.01.054. Epub 2015 Feb 7.
2015
ASL Città di Torino
AOU Città della Salute di Torino
Di Perri G; Brunati A; Nonnato A; Calvo PL; Pinon M; De Nicolò A; Pensi D; D'Avolio A;
Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferon. in Journal of viral hepatitis / J Viral Hepat. 2015 Mar;22(3):318-27. doi: 10.1111/jvh.12288. Epub 2014 Jul 24.
2015
ASL Città di Torino
Boglione L; Cusato J; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;
Candidemia, and infections by Clostridium difficile and carbapenemase-producing Enterobacteriaceae: new enteropathogenetic opportunistic syndromes? in Le infezioni in medicina / Infez Med. 2015 Jun;23(2):105-16.
2015
ASL Città di Torino
De Rosa FG; Corcione S; Raviolo S; Montrucchio C; Aldieri C; Pagani N; Di Perri G;
Intracellular accumulation of boceprevir according to plasma concentrations and pharmacogenetics. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2015 Jun;45(6):657-61. doi: 10.1016/j.ijantimicag.2015.01.019. Epub 2015 Ma
2015
ASL Città di Torino
Cusato J; Allegra S; De Nicolò A; Boglione L; Fatiguso G; Abdi AM; Cariti G; Di Perri G; D'Avolio A;
Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Jan;70(1):307-8. doi: 10.1093/jac/dku368. Epub 2014 Sep 18.
2015
ASL Città di Torino
Baietto L; D'Avolio A; Cusato J; Pace S; Calcagno A; Motta I; Corcione S; Di Perri G; De Rosa FG;
ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2015 Feb;69:63-9. doi: 10.1016/j.biopha.2014.11.007. Epub 2014 Nov 15.
2015
ASL Città di Torino
Cusato J; Allegra S; De Nicolò A; Boglione L; Fatiguso G; Cariti G; Ciancio A; Smedile A; Strona S; Troshina G; Rizzetto M; Di Perri G; D'Avolio A;
Role of pharmacogenetic in ribavirin outcome prediction and pharmacokinetics in an Italian cohort of HCV-1 and 4 patients. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2015 Feb;69:47-55. doi: 10.1016/j.biopha.2014.10.030. Epub 2014 Nov 6.
2015
ASL Città di Torino
Allegra S; Cusato J; De Nicolò A; Boglione L; Gatto A; Cariti G; Di Perri G; D'Avolio A;
Molecular characterization of toxigenic Clostridium difficile in a northern Italian hospital. in Current microbiology / Curr Microbiol. 2015 Feb;70(2):154-5. doi: 10.1007/s00284-014-0690-9. Epub 2014 Sep 23.
2015
ASL Città di Torino
De Rosa FG; Cavallerio P; Corcione S; Parlato C; Fossati L; Serra R; Di Perri G; Cavallo R;
Relationship between the early boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2015 Feb;21(2):205.e1-3. doi: 10.1016/j.cmi.2014.07.009. Epub 2014 Oct 29.
2015
ASL Città di Torino
Boglione L; De Nicolò A; Cardellino CS; Ruggiero T; Ghisetti V; Cariti G; Di Perri G; D'Avolio A;
Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment. in Archives of virology / Arch Virol. 2015 Aug;160(8):2009-17. doi: 10.1007/s00705-015-2482-3. Epub 2015 Jun 10.
2015
ASL Città di Torino
Boglione L; Cusato J; Allegra S; Cariti G; Di Perri G; D'Avolio A;
Pharmacokinetics of high dosage of linezolid in two morbidly obese patients. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Aug;70(8):2417-8. doi: 10.1093/jac/dkv126. Epub 2015 May 8.
2015
ASL Città di Torino
Corcione S; Pagani N; Baietto L; Fanelli V; Urbino R; Ranieri VM; Di Perri G; D'Avolio A; De Rosa FG;
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial. in Retrovirology / Retrovirology. 2015 Apr 29;12:33. doi: 10.1186/s12977-015-0151-y.
2015
ASL Città di Torino
Ensoli F; Cafaro A; Casabianca A; Tripiciano A; Bellino S; Longo O; Francavilla V; Picconi O; Sgadari C; Moretti S; Cossut MR; Arancio A; Orlandi C; Sernicola L; Maggiorella MT; Paniccia G; Mussini C; Lazzarin A; Sighinolfi L; Palamara G; Gori A; Angarano G; Di Pietro M; Galli M; Mercurio VS; Castelli F; Di Perri G; Monini P; Magnani M; et alii...
From ESKAPE to ESCAPE, from KPC to CCC. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2015 Apr 15;60(8):1289-90. doi: 10.1093/cid/ciu1170. Epub 2014 Dec 23.
2015
ASL Città di Torino
De Rosa FG; Corcione S; Pagani N; Di Perri G;
Re-defining tigecycline therapy. in The new microbiologica / New Microbiol. 2015 Apr;38(2):121-36. Epub 2015 Apr 21.
2015
ASL Città di Torino
De Rosa FG; Corcione S; Di Perri G; Scaglione F;
In Vitro Stabilifighty Evaluation of Different Pharmaceutical Products Containing Meropenem. in Hospital pharmacy / Hosp Pharm. 2015 Apr;50(4):296-303. doi: 10.1310/hpj5004-296. Epub 2015 Apr 8.
2015
ASL Città di Torino
Tomasello C; Leggieri A; Cavalli R; Di Perri G; D'Avolio A;
VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2015 Apr;25(4):164-72. doi: 10.1097/FPC.0000000000000123.
2015
ASL Città di Torino
Cusato J; Allegra S; Boglione L; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;
Treatment optimization of naïve HCV-1 patients using IL28B, RVR and fibrosis stage. in Antiviral research / Antiviral Res. 2015 Apr;116:45-7. doi: 10.1016/j.antiviral.2015.01.014. Epub 2015 Feb 7.
2015
ASL Città di Torino
Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;
Intracellular and Plasma Trough Concentration and Pharmacogenetics of Telaprevir. in Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques / J Pharm Pharm Sci. 2015;18(2):171-6. doi: 10.18433/j3dk6t.
2015
ASL Città di Torino
Cusato J; Allegra S; De Nicolò A; Boglione L; Fatiguso G; Mohamed Abdi A; Cariti G; Di Perri G; D'Avolio A;
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda. in Future microbiology / Future Microbiol. 2015;10(2):283-94. doi: 10.2217/fmb.14.121.
2015
ASL Città di Torino
De Rosa FG; Corcione S; Cavallo R; Di Perri G; Bassetti M;
Vitamin D pathway gene variants and HCV-2/3 therapy outcomes. in Antiviral therapy / Antivir Ther. 2015;20(3):335-41. doi: 10.3851/IMP2853. Epub 2014 Oct 3.
2015
ASL Città di Torino
Cusato J; Allegra S; Boglione L; De Nicolò A; Baietto L; Cariti G; Di Perri G; D'Avolio A;
The Effect on mortality of fluconazole or echinocandins treatment in candidemia in internal medicine wards [corrected]. in PloS one / PLoS One. 2015 May 4;10(5):e0125149. doi: 10.1371/journal.pone.0125149. eCollection 2015.
2015
ASL Città di Torino
De Rosa FG; Corcione S; Filippini C; Raviolo S; Fossati L; Montrucchio C; Aldieri C; Petrolo A; Cavallo R; Di Perri G;
Telaprevir-S isomer enhances ribavirin exposure and the ribavirin-related haemolytic anaemia in a concentration-dependent manner. in Antiviral research / Antiviral Res. 2014 Sep;109:7-14. doi: 10.1016/j.antiviral.2014.06.005. Epub 2014 Jun 20.
2014
ASL Città di Torino
De Nicolò A; Boglione L; Ciancio A; Cusato J; Strona S; Cardellino CS; Abdi AM; Cariti G; Troshina G; Caviglia GP; Smedile A; Rizzetto M; Di Perri G; D'Avolio A;
UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Sep;98:271-8. doi: 10.1016/j.jpba.2014.05.040. Epub 2014 Jun 7.
2014
ASL Città di Torino
De Nicolò A; Agnesod D; Simiele M; Riganò D; Adriani A; Canaparo R; Astegiano M; Rizzetto M; Di Perri G; D'Avolio A;
Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2014 Sep;69(9):2586-8. doi: 10.1093/jac/dku142. Epub 2014 May 8.
2014
ASL Città di Torino
Calcagno A; Nozza S; Simiele M; Milia MG; Chiappetta S; D'Avolio A; Ghisetti V; Lazzarin A; Di Perri G; Bonora S;
Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system. in Clinical pharmacokinetics / Clin Pharmacokinet. 2014 Oct;53(10):891-906. doi: 10.1007/s40262-014-0171-0.
2014
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S;
Prevalence and predictors of blood-brain barrier damage in the HAART era. in Journal of neurovirology / J Neurovirol. 2014 Oct;20(5):521-5. doi: 10.1007/s13365-014-0266-2. Epub 2014 Jun 28.
2014
ASL Città di Torino
Calcagno A; Alberione MC; Romito A; Imperiale D; Ghisetti V; Audagnotto S; Lipani F; Raviolo S; Di Perri G; Bonora S;
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2014 Nov;69(11):3061-6. doi: 10.1093/jac/dku234. Epub 2014 Jul 4.
2014
ASL Città di Torino
D'Avolio A; Carcieri C; Cusato J; Simiele M; Calcagno A; Allegra S; Sciandra M; Trentini L; Di Perri G; Bonora S;
Different HBsAg decline after 3 years of therapy with entecavir in patients affected by chronic hepatitis B HBeAg-negative and genotype A, D and E. in Journal of medical virology / J Med Virol. 2014 Nov;86(11):1845-50. doi: 10.1002/jmv.24038. Epub 2014 Aug 8.
2014
ASL Città di Torino
Boglione L; Cardellino CS; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;
Molecular epidemiology of methicillin-resistant S. aureus in the ICU setting. in Intensive care medicine / Intensive Care Med. 2014 May;40(5):759-60. doi: 10.1007/s00134-014-3257-0. Epub 2014 Mar 14.
2014
ASL Città di Torino
Corcione S; Motta I; Fossati L; Campanile F; Stefani S; Cavallo R; Di Perri G; Ranieri VM; De Rosa FG;
Lymphogranuloma venereum: an old, forgotten re-emerging systemic disease. in Panminerva medica / Panminerva Med. 2014 Mar;56(1):73-83. Epub 2014 Feb 11.
2014
ASL Città di Torino
Dal Conte I; Mistrangelo M; Cariti C; Chiriotto M; Lucchini A; Vigna M; Morino M; Di Perri G;
Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Mar;90:119-26. doi: 10.1016/j.jpba.2013.11.027. Epub 2013 Dec 1.
2014
ASL Città di Torino
Agnesod D; De Nicolò A; Simiele M; Mohamed Abdi A; Boglione L; Di Perri G; D'Avolio A;
Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines. in Le infezioni in medicina / Infez Med. 2014 Jun;22(2):107-11.
2014
ASL Città di Torino
De Rosa FG; Motta I; Corcione S; Cattel F; Di Perri G; D'Avolio A;
A validated HPLC-MS method for quantification of the CCR5 inhibitor maraviroc in HIV+ human plasma. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Jun;94:65-70. doi: 10.1016/j.jpba.2014.01.031. Epub 2014 Jan 31.
2014
ASL Città di Torino
Simiele M; Baietto L; Audino A; Sciandra M; Bonora S; Di Perri G; D'Avolio A;
Identification of naïve HVC-4 patients who may be treated with pegylated-interferon and ribavirin according to IL28B polymorphisms. in Antiviral research / Antiviral Res. 2014 Jun;106:105-10. doi: 10.1016/j.antiviral.2014.03.016. Epub 2014 Apr 12.
2014
ASL Città di Torino
Boglione L; Cusato J; De Nicolò A; Cariti G; Allegra S; Ghisetti V; Di Perri G; D'Avolio A;
Healthcare-associated Klebsiella pneumoniae carbapenemase producing K. pneumoniae bloodstream infection: the time has come. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2014 Jul 15;59(2):321-2. doi: 10.1093/cid/ciu294. Epub 2014 Apr 24.
2014
ASL Città di Torino
Corcione S; Cardellino CS; Calcagno A; Fossati L; Costa C; Cavallo R; Di Perri G; De Rosa FG;
Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitor regimens. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2014 Jul;58(7):4042-7. doi: 10.1128/AAC.00104-14. Epub 2014 May 5.
2014
ASL Città di Torino
De Nicolò A; Simiele M; Calcagno A; Abdi AM; Bonora S; Di Perri G; D'Avolio A;
Voriconazole and atazanavir: a CYP2C19-dependent manageable drug-drug interaction. in Pharmacogenomics / Pharmacogenomics. 2014 Jul;15(10):1281-6. doi: 10.2217/pgs.14.92.
2014
ASL Città di Torino
Calcagno A; Baietto L; Pagani N; Simiele M; Audagnotto S; D'Avolio A; De Rosa FG; Di Perri G; Bonora S;
The E genotype of hepatitis B: clinical and virological characteristics, and response to interferon. in The Journal of infection / J Infect. 2014 Jul;69(1):81-7. doi: 10.1016/j.jinf.2014.02.018. Epub 2014 Mar 14.
2014
ASL Città di Torino
Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;
Combination of conventional blood cultures and the SeptiFast molecular test in patients with suspected sepsis for the identification of bloodstream pathogens. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2014 Jul;79(3):287-92. doi: 10.1016/j.diagmicrobio.2014.03.018. Epub 201
2014
ASL Città di Torino
Burdino E; Ruggiero T; Allice T; Milia MG; Gregori G; Milano R; Cerutti F; De Rosa FG; Manno E; Caramello P; Di Perri G; Ghisetti V;
Triple or dual therapy for HCV-1 naive patients? Optimizing selection tools. in Journal of hepatology / J Hepatol. 2014 Jul;61(1):178-9. doi: 10.1016/j.jhep.2014.02.035. Epub 2014 Mar 21.
2014
ASL Città di Torino
Boglione L; De Nicolò A; Di Perri G; D'Avolio A;
Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Jan;88:66-70. doi: 10.1016/j.jpba.2013.08.022. Epub 2013 Aug 28.
2014
ASL Città di Torino
Baietto L; D'Avolio A; Pace S; Simiele M; Marra C; Ariaudo A; Di Perri G; De Rosa FG;
Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon. in Antiviral research / Antiviral Res. 2014 Feb;102:35-43. doi: 10.1016/j.antiviral.2013.11.014. Epub 2013 Dec 4.
2014
ASL Città di Torino
Boglione L; Cusato J; Allegra S; Esposito I; Patti F; Cariti G; Di Perri G; D'Avolio A;
Therapeutic drug monitoring of intracellular anti-infective agents. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Dec;101:183-93. doi: 10.1016/j.jpba.2014.03.040. Epub 2014 Apr 3.
2014
ASL Città di Torino
D'Avolio A; Pensi D; Baietto L; Di Perri G;
Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients. in Antiviral research / Antiviral Res. 2014 Aug;108:44-7. doi: 10.1016/j.antiviral.2014.05.009. Epub 2014 May 23.
2014
ASL Città di Torino
Calcagno A; Marinaro L; Nozza S; Aldieri C; Carbone A; Ghisetti V; Trentalange A; D'Avolio A; Castagna A; Di Perri G; Bonora S;
Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir. in Journal of viral hepatitis / J Viral Hepat. 2014 Apr;21(4):260-3. doi: 10.1111/jvh.12170. Epub 2013 Sep 2.
2014
ASL Città di Torino
Boglione L; De Nicolò A; Cusato J; Cariti G; Di Perri G; D'Avolio A;
Cerebrospinal fluid biomarkers in patients with plasma HIV RNA below 20 copies/mL. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19719. doi: 10.7448/IAS.17.4.19719. eCollection 2014.
2014
ASL Città di Torino
Calcagno A; Atzori C; Romito A; Ecclesia S; Imperiale D; Audagnotto S; Alberione MC; Trentalange A; Di Perri G; Bonora S;
Extra Corporeal Membrane Oxygenation (ECMO) in three HIV-positive patients with acute respiratory distress syndrome. in BMC anesthesiology / BMC Anesthesiol. 2014 May 21;14:37. doi: 10.1186/1471-2253-14-37. eCollection 2014.
2014
ASL Città di Torino
De Rosa FG; Fanelli V; Corcione S; Urbino R; Bonetto C; Ricci D; Rinaldi M; Di Perri G; Bonora S; Ranieri MV;
Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patients. in Current HIV research / Curr HIV Res. 2014;12(5):339-46. doi: 10.2174/1570162x12666140807151616.
2014
ASL Città di Torino
Bonora S; Calcagno A; Vigano O; Bigliano P; Marinaro L; Colella E; Orofino G; Trentini L; Tettoni MC; D'Avolio A; Mercadante S; Galli M; Di Perri G; Rusconi S;
Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service. in ClinicoEconomics and outcomes research : CEOR / Clinicoecon Outcomes Res. 2014 Sep 23;6:409-14. doi: 10.2147/CEOR.S68101. eCollection 2014.
2014
ASL Città di Torino
Restelli U; Andreoni M; Antinori A; Bonfanti M; Di Perri G; Galli M; Lazzarin A; Rizzardini G; Croce D;
Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Oct 1;936:42-7. doi: 10.1016/j.jchromb.2013.08.0
2013
ASL Città di Torino
Baietto L; D'Avolio A; Ariaudo A; Corcione S; Simiele M; Cusato J; Urbino R; Di Perri G; Ranieri VM; De Rosa FG;
High rate of respiratory MDR gram-negative bacteria in H1N1-ARDS treated with ECMO. in Intensive care medicine / Intensive Care Med. 2013 Oct;39(10):1880-1. doi: 10.1007/s00134-013-3012-y. Epub 2013 Jul 6.
2013
ASL Città di Torino
De Rosa FG; Corcione S; Pagani N; Stella ML; Urbino R; Di Perri G; Ranieri VM;
Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients. in Antiviral research / Antiviral Res. 2013 Oct;100(1):114-9. doi: 10.1016/j.antiviral.2013.07.021. Epub 2013 Aug 8.
2013
ASL Città di Torino
D'Avolio A; De Nicolò A; Cusato J; Ciancio A; Boglione L; Strona S; Cariti G; Troshina G; Caviglia GP; Smedile A; Rizzetto M; Di Perri G;
A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection. in Influenza and other respiratory viruses / Influenza Other Respir Viruses. 2013 Nov;7(6):1416-26. doi: 10.1111/irv.12146. Epub 2013 Aug 9.
2013
ASL Città di Torino
Ruggiero T; De Rosa F; Cerutti F; Pagani N; Allice T; Stella ML; Milia MG; Calcagno A; Burdino E; Gregori G; Urbino R; Di Perri G; Ranieri MV; Ghisetti V;
Recent outbreak of aseptic meningitis in Italy due to Echovirus 30 and phylogenetic relationship with other European circulating strains. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2013 Nov;58(3):579-83. doi: 10.1016/j.jcv.2013.08.023. Epub 2013 Aug 31.
2013
ASL Città di Torino
Milia MG; Cerutti F; Gregori G; Burdino E; Allice T; Ruggiero T; Proia M; De Rosa G; Enrico E; Lipani F; Di Perri G; Ghisetti V;
Pharmacokinetics and pharmacodynamics of etravirine 400 mg once daily in treatment-naïve patients. in HIV clinical trials / HIV Clin Trials. 2013 May-Jun;14(3):92-8. doi: 10.1310/hct1403-92.
2013
ASL Città di Torino
Di Perri G; Green B; Morrish G; Hill A; Faetkenheuer G; Bickel M; van Delft Y; Kurowski M; Kakuda T;
A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2013 May 5;78-79:217-23. doi: 10.1016/j.jpba.2013.02.025. Epub 2013 Feb 27.
2013
ASL Città di Torino
D'Avolio A; De Nicolò A; Agnesod D; Simiele M; Mohamed Abdi A; Dilly Penchala S; Boglione L; Cariti G; Di Perri G;
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2013 Jun;23(6):293-300. doi: 10.1097/FPC.0b013e3283606cb2.
2013
ASL Città di Torino
D'Avolio A; De Francia S; Basile V; Cusato J; De Martino F; Pirro E; Piccione F; Ardito A; Zaggia B; Volante M; Di Perri G; Terzolo M;
Telbivudine in the treatment of hepatitis B-associated cryoglobulinemia. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2013 Feb;56(2):167-9. doi: 10.1016/j.jcv.2012.10.014. Epub 2012 Nov 20.
2013
ASL Città di Torino
Boglione L; D'Avolio A; Cariti G; Di Perri G;
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis. in BMC infectious diseases / BMC Infect Dis. 2013 Dec 1;13:563. doi: 10.1186/1471-2334-13-563.
2013
ASL Città di Torino
De Rosa FG; Motta I; Audisio E; Frairia C; Busca A; Di Perri G; Marmont F;
Ultra performance liquid chromatography PDA method for determination of tigecycline in human plasma. in Therapeutic drug monitoring / Ther Drug Monit. 2013 Dec;35(6):853-8. doi: 10.1097/FTD.0b013e31829403b1.
2013
ASL Città di Torino
D'Avolio A; Peila E; Simiele M; Pensi D; Baietto L; Cusato J; Cinnirella G; De Rosa F; Di Perri G;
Mortality in patients with early- or late-onset candidaemia. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2013 Apr;68(4):927-35. doi: 10.1093/jac/dks480. Epub 2012 Dec 12.
2013
ASL Città di Torino
De Rosa FG; Trecarichi EM; Montrucchio C; Losito AR; Raviolo S; Posteraro B; Corcione S; Di Giambenedetto S; Fossati L; Sanguinetti M; Serra R; Cauda R; Di Perri G; Tumbarello M;
Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes. in Journal of viral hepatitis / J Viral Hepat. 2013 Apr;20(4):e11-9. doi: 10.1111/jvh.12018. Epub 2013 Feb 18.
2013
ASL Città di Torino
Boglione L; D'Avolio A; Cariti G; Milia MG; Simiele M; De Nicolò A; Ghisetti V; Di Perri G;
Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2013 Apr;68(4):907-10. doi: 10.1093/jac/dks484. Epub 2012 Dec 5.
2013
ASL Città di Torino
D'Avolio A; Simiele M; Calcagno A; Siccardi M; Larovere G; Agati S; Baietto L; Cusato J; Tettoni M; Sciandra M; Trentini L; Di Perri G; Bonora S;
Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D. in Liver international : official journal of the International Association for the Study of the Liver / Liver Int. 2013 Apr;33(4):580-5. doi: 10.1111/liv.12091. Epub 2013 Jan 14.
2013
ASL Città di Torino
Boglione L; D'Avolio A; Cariti G; Gregori G; Burdino E; Baietto L; Cusato J; Ghisetti V; De Rosa FG; Di Perri G;
Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2012 Nov;67(11):2645-9. doi: 10.1093/jac/dks285. Epub 2012 Aug 7.
2012
ASL Città di Torino
Baietto L; D'Avolio A; Marra C; Simiele M; Cusato J; Pace S; Ariaudo A; De Rosa FG; Di Perri G;
Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2012 Jul;66:376-80. doi: 10.1016/j.jpba.2012.03.030. Epub 2012 Mar 28.
2012
ASL Città di Torino
D'Avolio A; De Nicolò A; Simiele M; Turini S; Agnesod D; Boglione L; Cusato J; Baietto L; Cariti G; Calcagno A; Sciandra M; Di Perri G; Bonora S;
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC). in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2012 Feb 5;59:109-16. doi: 10.1016/j.jpba.2011.10.003. Epub 2011 Oct 14.
2012
ASL Città di Torino
D'Avolio A; Simiele M; De Francia S; Ariaudo A; Baietto L; Cusato J; Fava C; Saglio G; Di Carlo F; Di Perri G;
Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot study. in Infection / Infection. 2012 Feb;40(1):69-75. doi: 10.1007/s15010-011-0223-4. Epub 2011 Dec 2.
2012
ASL Città di Torino
Bonora S; Calcagno A; Cometto C; Fontana S; Aguilar D; D'Avolio A; Gonzalez de Requena D; Maiello A; Dal Conte I; Lucchini A; Di Perri G;
Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment. in Therapeutic drug monitoring / Ther Drug Monit. 2012 Dec;34(6):722-8. doi: 10.1097/FTD.0b013e318272e55a.
2012
ASL Città di Torino
D'Avolio A; Ciancio A; Siccardi M; Smedile A; Simiele M; Cusato J; Baietto L; Aguilar Marucco D; Cariti G; Calcagno A; Gonzalez de Requena D; Sciandra M; Troshina G; Caviglia GP; Bonora S; Rizzetto M; Di Perri G;
Inosine triphosphatase polymorphisms and ribavirin pharmacokinetics as determinants of ribavirin-associate anemia in patients receiving standard anti-HCV treatment. in Therapeutic drug monitoring / Ther Drug Monit. 2012 Apr;34(2):165-70. doi: 10.1097/FTD.0b013e31824bf778.
2012
ASL Città di Torino
D?Avolio A; Ciancio A; Siccardi M; Smedile A; Baietto L; Simiele M; Marucco DA; Cariti G; Calcagno A; de Requena DG; Sciandra M; Cusato J; Troshina G; Bonora S; Rizzetto M; Di Perri G;
A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2011 Mar 25;54(4):779-88. doi: 10.1016/j.jpba.2010.10.011. Epub 2010 Nov 10.
2011
ASL Città di Torino
D'Avolio A; Simiele M; Siccardi M; Baietto L; Sciandra M; Oddone V; Stefani FR; Agati S; Cusato J; Bonora S; Di Perri G;
Ceftriaxone bone penetration in patients with septic non-union of the tibia. in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases / Int J Infect Dis. 2011 Jun;15(6):e415-21. doi: 10.1016/j.ijid.2011.03.003. Epub 2011 Apr 15.
2011
ASL Città di Torino
Garazzino S; Aprato A; Baietto L; D'Avolio A; Maiello A; De Rosa FG; Aloj D; Siccardi M; Biasibetti A; Massè A; Di Perri G;
Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2011 Jun;55(6):2976-8. doi: 10.1128/AAC.01236-10. Epub 2011 Mar 14.
2011
ASL Città di Torino
Simiele M; D'Avolio A; Baietto L; Siccardi M; Sciandra M; Agati S; Cusato J; Bonora S; Di Perri G;
The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria. in Infection / Infection. 2011 Dec;39(6):555-61. doi: 10.1007/s15010-011-0201-x. Epub 2011 Nov 3.
2011
ASL Città di Torino
De Rosa FG; Pagani N; Fossati L; Raviolo S; Cometto C; Cavallerio P; Parlato C; Guglielmi E; Serra R; Di Perri G;
Anidulafungin treatment in a kidney transplant recipient with hepatic damage. in Mycoses / Mycoses. 2011 Dec;54 Suppl 4:12-5. doi: 10.1111/j.1439-0507.2011.02137.x.
2011
ASL Città di Torino
De Rosa FG; Manzione NA; Ranghino A; Messina M; Ottobrelli A; Raviolo S; Di Perri G; Segoloni GP;
Diagnosis of dengue fever in North West Italy in travelers from endemic areas: a retrospective study. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2011 Aug;51(4):259-63. doi: 10.1016/j.jcv.2011.05.011. Epub 2011 Jun 1.
2011
ASL Città di Torino
Burdino E; Milia MG; Sergi G; Gregori G; Allice T; Cazzato ML; Lucchini A; Lipani F; Calleri G; Orofino G; Di Perri G; Ghisetti V;
Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients. in Antiviral therapy / Antivir Ther. 2011;16(4):499-504. doi: 10.3851/IMP1802.
2011
ASL Città di Torino
Bonora S; Gonzalez de Requena D; D'Avolio A; Calcagno A; Tettoni M; Siccardi M; Baietto L; Simiele M; Trentini L; Di Perri G;
HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2010 Sep 5;52(5):774-80. doi: 10.1016/j.jpba.2010.02.026. Epub 2010 Feb 25.
2010
ASL Città di Torino
D'Avolio A; Simiele M; Siccardi M; Baietto L; Sciandra M; Bonora S; Di Perri G;
Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma. in Analytical and bioanalytical chemistry / Anal Bioanal Chem. 2010 Jan;396(2):791-8. doi: 10.1007/s00216-009-3263-1. Epub 2009 Nov 9.
2010
ASL Città di Torino
Baietto L; D'Avolio A; De Rosa FG; Garazzino S; Michelazzo M; Ventimiglia G; Siccardi M; Simiele M; Sciandra M; Di Perri G;
A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients. in Therapeutic drug monitoring / Ther Drug Monit. 2010 Feb;32(1):86-92. doi: 10.1097/FTD.0b013e3181cacbd0.
2010
ASL Città di Torino
D'Avolio A; Simiele M; Baietto L; Siccardi M; Sciandra M; Patanella S; Bonora S; Di Perri G;
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2010 Dec;20(12):759-65. doi: 10.1097/FPC.0b013e3283402efb.
2010
ASL Città di Torino
Siccardi M; D'Avolio A; Nozza S; Simiele M; Baietto L; Stefani FR; Moss D; Kwan WS; Castagna A; Lazzarin A; Calcagno A; Bonora S; Back D; Di Perri G; Owen A;
Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2010 Aug;54(8):3408-13. doi: 10.1128/AAC.01807-09. Epub 2010 Jun 7.
2010
ASL Città di Torino
Baietto L; D'Avolio A; Ventimiglia G; De Rosa FG; Siccardi M; Simiele M; Sciandra M; Di Perri G;
Combination antifungal treatment of pseudomembranous tracheobronchial invasive aspergillosis: a case report. in Intensive care medicine / Intensive Care Med. 2009 Sep;35(9):1641-3. doi: 10.1007/s00134-009-1546-9. Epub 2009 Jun 16.
2009
ASL Città di Torino
De Rosa FG; Terragni P; Pasero D; Trompeo AC; Urbino R; Barbui A; Di Perri G; Marco Ranieri V;
Management of H1N1 influenza virus respiratory syndrome. in Minerva anestesiologica / Minerva Anestesiol. 2009 Nov;75(11):654-60.
2009
ASL Città di Torino
De Rosa FG; Montrucchio C; Di Perri G;
Invasive candidiasis and candidemia: new guidelines. in Minerva anestesiologica / Minerva Anestesiol. 2009 Jul-Aug;75(7-8):453-8. Epub 2008 Jan 24.
2009
ASL Città di Torino
De Rosa FG; Garazzino S; Pasero D; Di Perri G; Ranieri VM;
Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV. in Therapeutic drug monitoring / Ther Drug Monit. 2009 Feb;31(1):104-9. doi: 10.1097/FTD.0b013e31819476fa.
2009
ASL Città di Torino
Baietto L; D'Avolio A; De Rosa FG; Garazzino S; Patanella S; Siccardi M; Sciandra M; Di Perri G;
Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2008 Nov 1;47(9):1222-5. doi: 10.1086/592304.
2008
ASL Città di Torino
Siccardi M; D'Avolio A; Baietto L; Gibbons S; Sciandra M; Colucci D; Bonora S; Khoo S; Back DJ; Di Perri G; Owen A;
Cryoglobulinemia-related vasculitis during effective anti-HCV treatment with PEG-interferon alfa-2b. in Infection / Infection. 2008 Jun;36(3):285-7. doi: 10.1007/s15010-007-6299-1. Epub 2007 Oct 25.
2008
ASL Città di Torino
De Blasi T; Aguilar Marucco D; Cariti G; Maiello A; De Rosa FG; Di Perri G;
A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients. in Journal of chromatographic science / J Chromatogr Sci. 2008 Jul;46(6):524-8. doi: 10.1093/chromsci/46.6.524.
2008
ASL Città di Torino
D'Avolio A; Sciandra M; Siccardi M; Baietto L; Gonzalez de Requena D; Bonora S; Di Perri G;
Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins. in The Journal of infection / J Infect. 2008 Jul;57(1):78-81. doi: 10.1016/j.jinf.2008.05.005. Epub 2008 Jun 11.
2008
ASL Città di Torino
Bonora S; Mondo A; Trentini L; Calcagno A; Lucchini A; Di Perri G;
SPIR01 and SPIR02: a two-year 1-day point prevalence multicenter study of infections in intensive care units in Piedmont, Italy. in The new microbiologica / New Microbiol. 2008 Jan;31(1):81-7.
2008
ASL Città di Torino
ASL Torino 3
De Rosa FG; Garazzino S; Audagnotto S; Bargiacchi O; Zeme DA; Gramoni A; Barberis B; Ranieri VM; Di Perri G;
A simple and fast method for quantification of ertapenem using meropenem as internal standard in human plasma in a clinical setting. in Therapeutic drug monitoring / Ther Drug Monit. 2008 Feb;30(1):90-4. doi: 10.1097/FTD.0b013e31815f4f7e.
2008
ASL Città di Torino
D'Avolio A; Baietto L; De Rosa FG; Garazzino S; Sciandra M; Siccardi M; Bonora S; Di Perri G;
An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients. in Therapeutic drug monitoring / Ther Drug Monit. 2008 Dec;30(6):662-9. doi: 10.1097/FTD.0b013e318189596d.
2008
ASL Città di Torino
D'Avolio A; Baietto L; Siccardi M; Sciandra M; Simiele M; Oddone V; Bonora S; Di Perri G;
HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Nov 15;859(2):234-40. doi: 10.1016/j.jchromb.200
2007
ASL Città di Torino
D'Avolio A; Siccardi M; Sciandra M; Baietto L; Bonora S; Trentini L; Di Perri G;
Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2007 Mar;59(3):565-8. doi: 10.1093/jac/dkl497. Epub 2007 Jan 9.
2007
ASL Città di Torino
Aguilar Marucco D; Veronese L; de Requena DG; Bonora S; Calcagno A; Cavecchia I; Sinicco A; De Rosa FG; Cariti G; Di Perri G;
Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV-infected patients. in Infection / Infection. 2007 Jun;35(3):154-60. doi: 10.1007/s15010-007-5125-0.
2007
ASL Città di Torino
De Rosa FG; Cicalini S; Canta F; Audagnotto S; Cecchi E; Di Perri G;
A short course of pegylated interferon-alpha in acute HCV hepatitis. in Journal of viral hepatitis / J Viral Hepat. 2007 Feb;14(2):116-21. doi: 10.1111/j.1365-2893.2006.00802.x.
2007
ASL Città di Torino
Calleri G; Cariti G; Gaiottino F; De Rosa FG; Bargiacchi O; Audagnotto S; Quaglia S; De Blasi T; Romano P; Traverso A; Leo G; Carbone R; Del Mastro B; Tinelli M; Caramello P; Di Perri G;
A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 1;848(2):374-8. doi: 10.1016/j.jchromb.2006.
2007
ASL Città di Torino
D'Avolio A; Sciandra M; Siccardi M; Baietto L; de Requena DG; Bonora S; Di Perri G;
Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient. in The Journal of infection / J Infect. 2006 Nov;53(5):e215-8. doi: 10.1016/j.jinf.2006.01.023. Epub 2006 Mar 20.
2006
ASL Città di Torino
De Rosa FG; Audagnotto S; Bargiacchi O; Garazzino S; Aguilar Marucco D; Veronese L; Canta F; Bonora S; Sinicco A; Di Perri G;
Validation of liquid/liquid extraction method coupled with HPLC-UV for measurement of ribavirin plasma levels in HCV-positive patients. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2006 May 1;835(1-2):127-30. doi: 10.1016/j.jchromb.20
2006
ASL Città di Torino
D'Avolio A; Ibañez A; Sciandra M; Siccardi M; de Requena DG; Bonora S; Di Perri G;
An improved HPLC fluorimetric method for the determination of enfuvirtide plasma levels in HIV-infected patients. in Therapeutic drug monitoring / Ther Drug Monit. 2006 Feb;28(1):110-5. doi: 10.1097/01.ftd.0000179421.25337.62.
2006
ASL Città di Torino
D'Avolio A; Sciandra M; de Requena DG; Ibañez A; Bonora S; Di Perri G;
Pharmacodynamic analysis of antimalarials used in Plasmodium falciparum imported malaria in northern Italy. in Journal of travel medicine / J Travel Med. 2005 May-Jun;12(3):127-32. doi: 10.2310/7060.2005.12305.
2005
ASL Città di Torino
Caramello P; Canta F; Cavecchia I; Sergi G; Lipani F; Calleri G; Gobbi F; Di Perri G;
Osteomyelitis caused by Enterobacter cancerogenus infection following a traumatic injury: case report and review of the literature. in Journal of clinical microbiology / J Clin Microbiol. 2005 Mar;43(3):1459-61. doi: 10.1128/JCM.43.3.1459-1461.2005.
2005
ASL Città di Torino
Garazzino S; Aprato A; Maiello A; Massé A; Biasibetti A; De Rosa FG; Di Perri G;
Chemosusceptibility analysis of Plasmodium falciparum imported malaria in Italy. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2005 Jun;52(2):107-12. doi: 10.1016/j.diagmicrobio.2005.01.002.
2005
ASL Città di Torino
Caramello P; Canta F; Cavecchia I; Sergi G; Balbiano R; Ariaudo S; Audagnotto S; Di Perri G;
Blackwater fever in children, Burundi. in Emerging infectious diseases / Emerg Infect Dis. 2005 Jul;11(7):1118-20. doi: 10.3201/eid1107.041237.
2005
ASL Città di Torino
Gobbi F; Audagnotto S; Trentini L; Nkurunziza I; Corachan M; Di Perri G;
Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis? in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2004 Sep;54(3):593-602. doi: 10.1093/jac/dkh377. Epub 2004 Jul 28.
2004
ASL Città di Torino
Di Perri G; Bonora S;
Candida albicans and HIV-1 Infection. in Cell biochemistry and function / Cell Biochem Funct. 2000 Dec;18(4):235-41. doi: 10.1002/1099-0844(200012)18:4<235::AID-CBF877>3.0.CO
2000
ASL Città di Torino
Pugliese A; Torre D; Baccino FM; Di Perri G; Cantamessa C; Gerbaudo L; Saini A; Vidotto V;